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Infectious pathogens are a prominent threat to human health in the world. There is a 
ubiquitous need for safe and reliable pathogen inactivation in the entire health care sector 
and pharmaceutical industry. Unfortunately, existing chemical treatment methods for virus 
inactivation have shortcomings as they introduce toxic chemicals or alter the structure of 
the products, which often pose significant side effects. Furthermore, considering the 
alarming growth of antibiotic resistances and hospital associated microbial infections, there 
is an urgent need for alternative pathogen inactivation strategies. Femtosecond (fs) pulsed 
laser irradiation technique is a promising solution free of added toxic chemicals and does 
not require the invention of new antibiotics for inactivation of virus contaminations in 
biological samples. Conventional pulsed laser techniques require relatively long irradiation 
times to achieve a significant viral inactivation. This thesis is focused on developing a 
novel photonic inactivation approach that is selective to pathogens, doesn’t compromise 
the protein-based pharmaceuticals, and is obtained without specific targeting to the 
pathogens.  
In our study, we report comparative studies using femtosecond laser pulses generated 
 
 viii 
using Chirped Pulse Amplification (CPA) centered at either 800 nm or frequency-doubled 
400 nm wavelengths, on the model bacteriophage φX174.  We show that photonic 
inactivation is wavelength dependent and a Log Reduction Value (LRV) of > 6 in a 2 ml 
bacteriophage sample volume is achieved with less than 1 min of 400 nm laser exposure. 
Traditional methods for assaying viral inactivation require cell culture studies that can take 
up to 48–72 hours. We describe a solid-state nanopore technique that can monitor the effect 
of this optical viral therapy in under 10 minutes. By developing a statistical model based 
on the probability distribution function obtained from nanopore data, we monitor the 
survival fraction of viruses with low sample volume, high precision and fast assay time. 
Lastly, the purely photonic virus inactivation requires UV fs laser irradiation, which can 
risk photodamage to biologics. In our research, we introduce a novel inactivation approach 
that takes advantage of the strong light-matter interactions provided by noble metal 
nanoparticle (NP) structures that sustain plasmons. We report a plasmonically enhanced 
virus inactivation of Murine Leukemia Virus (MLV) via 10 s laser exposure with 800 nm 
fs pulses through gold nanorods, with LRV>3.7. We demonstrate that this NP-enhanced, 
physical inactivation approach is effective against a diverse group of pathogens, including 
both enveloped and non-enveloped viruses, and a variety of bacteria and mycoplasma. 
Importantly, the fs-pulse induced inactivation was selective to the pathogens and did not 
induce any measurable damage to co-incubated antibodies, or to large mammalian cells.  
 Based on the observations, a model of selective pathogen inactivation based on plasmon 
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CHAPTER ONE: Introduction 
Contamination of cell culture medium with microbes is a well-recognized1 problem for 
the safe fabrication of biologics, and also poses a challenge  for  reproducibility in 
fundamental research. Biologics are pharmaceutical compounds synthesized or extracted 
from a biological source such as plant or animal cells or a microorganism.2 They form the 
fastest growing drug category that impacts and improves patient outcomes for a broad 
range of diseases. Microbial contaminations can lead to changes in the composition of the 
bioreactor used to generate biologics with mammalian cells, potentially induce a loss in the 
potency due to degradation, and can by themselves be harmful for human health. There is, 
consequently, a ubiquitous need for the safe and reliable inactivation and removal of 
viruses3, mycoplasma4, and bacteria in the pharmaceutical industry. Furthermore, 
considering the alarming growth of antibiotic resistances and hospital associated microbial 
infections, there is an urgent need for alternative microbial inactivation strategies in the 
entire health care sector. This thesis will develop and validate a new plasmon-enhanced 
microbial pathogen inactivation technology and elucidate its mode of action against 
viruses, mycoplasma, and bacteria. Our results show that this technique is selective to 
pathogens while does not require targeting or the use of covalently bound molecular labels 
to pathogens for the inactivation. 
In biology, a pathogen is a biological agent that causes disease or illness to its host (man, 
animals or plants). Although there are different group of these disease-causing 
microorganisms that include viruses (e.g. hepatitis virus), bacteria (e.g. salmonellae), fungi 
(e.g. Aspergillus), protozoa (e.g. Cryptosporidium) and helminths (e.g. Taenia)5,  in this 
 
2 
thesis we focus on bacteria and viruses which are known source of microbial contamination 
in pharmaceutical products 6. 
 
Viruses  
A virus is a molecular genetic obligate parasite, which is an organism that cannot 
reproduce independently and lives in another organism for its own replication. 7 There are 
an estimated 1031 viruses on Earth. 8 That’s a lot! Astronomy used to deal with large 
numbers, but these numbers can be dwarfed when compared with life on the microbial 
scale.  If we have ever wondered how many stars are in the sky, the answer is 7 × 10%%. 
Moving onto earth, the number of microorganisms in a teaspoon of soil is 109 which is the 
same as the number of humans currently living in Africa. Perhaps the scariest numbers in 
microbiology is related to the pathogenic microorganisms so that in each year, 16 million 
people die from infectious disease worldwide.9 This means that it is necessary to improve 
our understanding about pathogens and inactivation techniques. 
Due to the large number of viruses, they vary over a huge range in their sizes and shapes. 
The size of a typical virus is about 17 nanometers in diameter up to 1 micrometer in their 
greatest dimension, which are hardly visible with a light microscope. Viruses are typically 
10 to 100 times smaller than bacteria and are comparable to molecules in size; for example, 
a hydrogen atom is about 1 angstrom in diameter.  
However, viruses still have a few features in common including genetic elements (DNA 
or RNA), a protective protein shell called capsid and a layer of membrane (some have but 
not all viruses).   The genetic elements made of nucleic acid, which may be single-stranded 
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(ss) or double-stranded (ds). Based on the type of genome, viruses are places into one of 
seven groups according to the Baltimore classification10(Figure 1-1), proposed by David 
Baltimore, Nobel laureate in 1975. Baltimore classification is a statement of how viruses 
fit their style of handling genetic information into the needs of central dogma which is the 
flow of information in gene expression as from nucleic acid to protein.11 
The viral genome is surrounded by capsid which protects it from degradation. 12 In a class 
of virus called “non-enveloped viruses”, specialized protein structures on the surface of 
capsids acts as ligands to cellular receptors, during the infection process (Figure 1-2).  
Examples of non-enveloped viruses is φX174 bacteriophage and hepatitis A virus. Certain 
viruses belong to “enveloped viruses” class, such as MLV and HIV that have an envelope 
 
 
Figure 1-1 The Baltimore classification clusters viruses into seven families based on their type of 
genome. Reprinted from Molecular virology of human pathogenic viruses, by Ryu, Wang-Shick, 
Academic Press, 2016. 12 
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around the capsid, and is rich in proteins and lipids molecules. The envelope proteins 
within the lipid membrane act as ligands for cellular binding. 13 
A comprehensive viral clearance database with focus on monoclonal antibody (mAb) 
fabrication was compiled by Miesegaes and collaborators at the FDA and highlights the 
threat of viral contamination to mAb fabrication.14 Contamination can arise from both 
enveloped and non-enveloped viruses, and viruses of particular concern include Porcine 
circovirus, Murine Minute Virus (MMV), and Murine Leukemia Virus (MLV).15-16  
 
Bacteria  
Bacteria, the most ancient of organisms, have an extraordinary ability to adapt to diverse 
environmental conditions such as human body, water, and soil.17 These organisms that 
usually measure a few micrometers in length are characterized by a lack of a nucleus.18  The 
 
 
Figure 1-2 Morphologic Characteristics of nonenveloped and enveloped Viruses. Adapted from 
Pathologic Basis of Veterinary Disease Expert Consult-E-BOOK, by Zachary, James F., and M. 





direct estimate of the total number of bacteria on earth is five million trillion trillion – that 
is 5 × 10'(. 19 There are different types of bacteria which can be classified based on many 
factors such as morphology, DNA sequencing, staining methods, cell structure and etc.20  
Cell surfaces of bacteria are heterogeneous mixtures contain lipids, glycans and proteins. 
These molecular structures are responsible for providing structural support for bacteria and 
mediating their interactions with the surrounding environment. Differences in molecular 
structures of the cell surface form the basis for the classification of bacteria into two main 
categories: Gram-positive and Gram-negative. As show in Figure 1-3, a single lipid bilayer 
and a thick layer of peptidoglycan are the main content of the Gram-positive bacteria.21 
The designation of Gram-positive is based on the results of Gram staining method, which 
retains the Gram stain via the peptidoglycan scaffold. Conversely, the Gram-negative 
 
 
Figure 1-3 Cell walls of gram –positive and gram-negative bacteria. The gram-positive micrograph 
on left is Bacillus licheniiformis, while the gram-negative on the right is Aquaspirillum serpens. The 
following abbreviation are used: IM: plasma membrane; PM: peptidoglycan layer; OM: outer 
membrane; P: periplasmic space; W: gram-positive peptidoglycan wall. Adapted from 
Microbiologia Médica de Jawetz, Melnick & Adelberg-26., by Brooks, Geo F., et al., AMGH 
Editora, 2014.21 
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bacteria contain two lipid bilayers that are separated by a thin layer of peptidoglycan are 
unable to retain the Gram stain.21 The additional outer membrane found in Gram-negative 
organisms reduces the permeation of the Gram stain. This protective outer lipid membrane 
also prevents the facile passage of most antibiotics which makes Gram-negative bacterial 
species more robust against antibiotics. 
There is a third form of bacteria which is wall-less such as Mycoplasma species. This 
characteristic makes them more resistant to common antibiotics.  Mycoplasma, which are 
known to be one of the smallest free-living forms of bacteria, possess a single membrane 
and ranging in size from 0.15 to 0.3 micrometers. 22 These bacteria are well-known 
contaminants in cell culture. 23 The small size of these bacteria enables them to escape lots 
of filtration systems and grow to a high concentration in cell culture. Bacterial 
contamination, in particular related to mycoplasma, which can continue to grow even under 
refrigerated conditions, is currently a probable cause for batch failure in biopharmaceutical 
production.4  For several year, cell lines have been used to produce a number of biological 
products for therapeutic or medicinal application, such as viral vaccines and monoclonal 
antibodies. Due to the extensive effects of mycoplasma strains on cell line physiology, 
metabolism, and gene expression; mycoplasma contamination of cell lines presents a 
significant safety and economic concern in pharmaceutical industry which can result in 
loss of months of invaluable production time and tens or hundreds of thousands of dollars 




Sterilization of Monoclonal Antibody Pharmaceuticals 
Monoclonal antibody (mAb) therapy has emerged as one of the most exciting and 
successful therapeutic strategies for some cancer tumors in the last 20 years.25-26 This 
treatment strategy uses monoclonal antibodies made in a lab engineered to specifically 
target the cancer cells. The fabrication of mAbs is a biopharmaceutical process in which 
harsh chemical or thermal sterilization approaches are not permissible, since it could result 
in direct harm and denaturation of the proteins. Regulatory agencies consider aseptic 
sterilization of a biopharmaceutical process insufficient and require a terminal sterilization 
step for mAbs.27-29 Virus Clearance is one of the major challenges in biopharmaceutical 
industry, especially in the manufacturing of drugs. As conventional virus inactivation 
strategies risk loss of mAb activity, the best final clearance method in current practice is 
passive filtration.30 Virus filtration is among the most robust methods that is based on size 
exclusion of porous membranes. Filtration is also the preferred method to remove bacterial 
contaminations, including mycoplasma. A key challenge for viral and mycoplasma 
clearance by filtration is, however, the small size of the organisms. Given the size of small 
viruses, ~18 nm, which is very close to some of the large mAb molecules, ~10 nm; size 
selectivity is critical for filtration. Mycoplasma also can pass through 200 nm filter pores 
and the filter size requirements are stringent for Mycoplasma and small viruses. Figure 1-
4 shows the size comparison of biological substances. Hence, it remains challenging to 
discriminate between small virus and antibody and ensure a safe biopharmaceutical drug 
with conventional nanofiltration devices. Although bacteria that are larger than 
mycoplasma can be effectively removed by filtration, filter membranes have limited 
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capacity and represent potential sources of contamination. Given the tremendous medical 
relevance of mAb biologics, alternative inactivation strategies that are effective against the 
broad spectrum of potential contaminants, including viruses, mycoplasma and bacteria but 
eliminate the risk of microbial contamination and reduce mAb production cost have high 
public health relevance. 31 
 
Pathogen Reduction Strategies 
Generally, infectious pathogens are a prominent threat to human health and among the 
top offenders are microorganisms such as viruses and bacteria. Some of these pathogens 
can escape the conventional chemical and biological treatments through genetic mutation 
such as HIV. Instead of becoming trapped in the conventional chemical technique, we 
zooming out to view the entire field, and explore a more definitive inactivation method of 
destroying pathogens.  
As stated above, a scheme that can effectively remove or inactivate a broad range of 
pathogens without causing collateral damage to antibody pharmaceuticals has great 
 
Figure 1-4 Diagram of the relative sizes of biological substances, antibody, virus, bacteria and cell. 
Reprinted from food freedom wordpress. 32 
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relevance for human and animal health. Existing chemical treatment methods for virus 
inactivation have shortcomings as they introduce toxic chemicals or alter the structure of 
the products which often pose significant side effect. Physical methods based on thermal 
treatment,32  or gamma and ultraviolet UV light radiation33-34  need long irradiation times 
that adversely affect thermolabile compounds and risk the denaturation of biomolecules of 
interest in the medium containing the virus. As mentioned earlier the current best practice 
for final viral clearance is passive filtration30 which has a challenge in reliable removal of 
small size pathogen contaminants  such as mycoplasma35 and parvovirus with a 
characteristic diameter between 18–26 nm.36 So in the pharmaceutical industry, alternative 
inactivation and removal strategies of viruses3, mycoplasma4, and bacteria37 are needed.   
A potential alternative to filtration that has recently attracted interest is photonic 
sterilization with pulsed laser sources. The groups of Tsen and Achilefu have shown that 
ultrafast lasers can inactivate non-enveloped viruses, enveloped viruses, bacteria, and 
yeast38. Table 1 summarizes the log reduction value (LRV) of various viruses inactivated 
by the femtosecond pulsed laser technology. As shown in Equ.1-1, LRVs are determined 
by taking the logarithm of the ratio of pathogen concentration in the control (Cu) and laser 
exposed sample (CT).  
As Table 1 shows, the conventional photonic virus inactivation and the predominant use 
of near-UV lasers requires long femtosecond laser irradiation time, which risks 


















exposure duration  
 
Irradiance range  
M13, TMV, HPV,HIV39 776 nm 2 hr 60 - 1100 MW/cm2 
Influenza Virus40, 
MNV41, MCMV42, M1343 425 nm 2 hr-10 hr <100 MW/cm
2 
M1344 850 nm 1 hr 60 MW/cm2 
Table 1. Viral inactivation using a femtosecond pulsed laser. 
 
Besides viruses there are another real world samples risk contaminations which are 
Gram-positive or Gram-negative bacteria and mollicute bacteria (i.e. mycoplasma).  Thus 
there is a need for reliable inactivation strategy that can efficiently inactivate biologically-
diverse pathogens. Only a few studies have investigated the feasibility of inactivating 
bacterial pathogens, such as E. coli, S. typhi, L. monocytogenes and, E. sakazakii using 
photonic inactivation technique 45-46.  E. coli bacteria inactivation up to 3 LRV has been 
reported by Lu et al. 47 with 1 hr exposure of ultrashort 415 nm light pulses with a laser 
power density of 3.5 GW/cm2 47. Also Gram-positive bacteria such as Listeria and Gram-
negative bacteria such as E. coli and S. typhimurium could be inactivated by LRV of 2.4, 
2.4, and 3.1, respectively, upon irradiation with a 100 fs laser working at 415±5 nm for 1.5 
h.38 The number of studies on the photonic inactivation of mycoplasma with ultrafast lasers 
are very limited. A. laidlawii and M. orale photonic inactivation with only ~2 LRV is 
reported by Tsen et al. 48 But the point is that generally, the reduction value obtained for 
bacteria and mycoplasma using photonic inactivation techniques are still insufficient for 
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clearance purposes. This motivates us to improve the photonic strategies for broad range 
of pathogens. 
This thesis is focused on developing a novel treatment system, capable of inactivating a 
broad spectrum of pathogens in both batch mode and flow through mode, without 
compromising the desirable protein-based components using plasmonic NPs.  
 
Gold Nanoparticles: Properties and Therapeutic applications 
Plasmonic NPs have unique optical properties that are determined by coherent 
conduction band electron density oscillations, so-called localized surface plasmon 
resonances (LSPRs).49-50 LSPR are generated when light over a characteristic frequency 
range interacts with conductive nanoparticles (NPs) that are smaller than the incident 
wavelength (Figure 1-5).51,52 The coherent localized plasmon oscillations happens at a 
resonant frequency that strongly depends on the size, geometry, composition, and dielectric 
environment of NPs. Noble metals such as silver and gold are common materials used for 
NP production which exhibit LSPR in the visible range of the spectrum.53 Although, silver 
 
Figure 1-5. Schematic illustration of localized surface plasmon in a metallic nanoparticle with radius 




has a sharper and stronger band compared to gold, gold is preferred for biological 
applications due to its inert nature, biocompatibility, and the development of robust thiol-
gold chemistry for immobilization of biomolecules. In the last twenty years, different 
nanoparticle-based therapeutic and diagnostic agents have been developed for the 
treatment of cancer, infections, and so on.54-55 Modern biomedical techniques can 
successfully treat some cancer cells via plasmon-mediated photothermal therapy. In 
photothermal therapy, metallic nanoparticles act as intense heaters and destroy the cancer 
cells.56-57  
Different efficient broadband gold plasmonic nanostructures58-60 exist that can generate 
high local heat and can also enhance E-field in electromagnetic hot-spots. By controlling 
the synthesis of the nanoparticles, it is possible to modulate the size and shape of the 
particles to obtain the desired response for the application of interest. For example, gold 
nanorods (NRs) with an aspect ratio (the ratio of the length of nanorod L, to its width, W) 
of ~3.6 sustain a longitudinal plasmon mode that peaks close to the 805 nm and transverse 
mode around 520 nm (Figure 1-6).  
 







Recently, there has been significant interest in the NPs due to the nanoscale plasma 
generation around plasmonic NPs. It was concluded that under fs-pulsed laser irradiation, 
the intense field surrounding plasmonic NPs can induces cavitation, which can generate 
pressure (and shock) waves and spread over a large volume.61-63  The idea underlying our 
plasmonically enhance pathogen inactivation technique is to use tailor-made plasmonic 
nanoparticles with different morphology such as gold nanorods and gold bipyramids (BPs) 
and operate in an optical wavelength range with minimal collateral damage to co-incubated 
antibodies (Figure 1-7).  
When these specially engineered nanoparticles are exposed to an ultra-short laser pulse 
near resonance, a quantum state far from equilibrium is formed by collective excitation of 
electrons and can transfer a huge amount of energy into the surrounding medium which 















Generally, the optical responses of LSPs are analyzed using classical electromagnetism, 
and the LSP antenna effect can be explained simply by Maxwell’s equations. But as the 
feature size of plasmonic structures shrinks further, the classical descriptions of field 
dynamics might become insufficient, and quantum mechanical effects such as non-local 
and tunneling effects, emerge. In these cases, the study of the fundamental physics of LSPs 
requires a quantum-mechanical treatment of plasmons. So quantum plasmonics would be 
needed to understand of the plasmonic response of nano-plasmonic systems. 64-66 
 
Probing Particles using Nanopore 
The ultrashort-pulsed laser technology presented in previous sections can be readily used 
for the rapid and effective inactivation of viruses. Conventionally, a quantitative evaluation 
of inactivation requires bacterial cell culture studies on Agar plates which can take up to 
48–72 hours for the bacterial colonies to form plaques that can be counted with sufficient 
statistics.   Physical changes in the morphology of viruses provide an intrinsic signature 
that can be used to measure inactivation. In thesis, we show that a solid-state nanopore 
conductance technique allows us to detect intact viruses and monitor the effect of fs laser 
on a model virus at the single virus level. A solid state nanopore is typically a nm-sized 
hole formed in a synthetic membrane such as Silicon nitride or silica. The nanopore is 
usually fabricated by focused ion or electron beams, so that the size of the pore can be 
tuned. Nanopores as single-particle electrical sensors, have been used for understanding 
DNA transport67-69 quantifying the conformational properties of proteins,70-76 and detecting 
small molecules, 77-78 among many other applications. Some studies have also explored the 
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ability of nanopore sensors to detect spherical and icosahedral viruses,79  virus capsids,80 
the masses and zeta potentials of viruses,81-82 and the translocation of a stiff, rod-shaped 
virus.83  
The ability of nanopores to detect the translocation of nanometer size particles motivated 
us to study the effect of the ultrashort-pulsed laser viral inactivation technique on a single 
virus level, which is crucial for the preparation of safe biotherapeutics. 
Nanopore conductance measurements provide information on morphological changes at 
the level of a single virion. By analyzing a time series of nanopore conductance data we 
quantify the detection of inactivation, which requires only a few minutes. As mentioned 
above, in the nanopore conductance technique, a single nm-scale pore is embedded in a 
membrane which separates the two chambers, called the cis- and trans- chambers, that 
contains electrolyte solution and analytes (Figure 1-8). A DC voltage is applied across the 
pore to initiate a flow of current and drive charged molecules across the pore. The passage 
of an individual virus particle through the pore reduces the instantaneous ionic current, 
 
Figure 1-8 Schematic view of the nanopore virus detection system. Voltage is applied across a 









which results in a downward spike in the current. There are three key independent 
parameters that can be extracted from the nanopore data: (i) the dwell time of viruses at the 
pore, that is the duration in which a virus is sustained inside the nanopore; (ii) the fractional 
current blockade, which is defined as a ratio between the change in the current when the 
pore is blocked and the mean open pore current; and (iii) the inter-event waiting time, from 
which virus capture rates can be extracted.  This information can be used to identify the 
virus features such as surface charge, size and shape.  
 
Thesis Overview 
This dissertation describes an optical pathogen inactivation technique that is selective 
and can be readily used for the rapid and effective inactivation of viruses and bacteria 
without requiring targeting or the use of covalently bound molecular labels. There is 
significant concern associated with exposing biological samples to short wavelength 
radiation, especially pulsed laser radiation that photon energies overlap with electronic 
transitions in biomolecules (DNA, RNA, and proteins). Absorption of short wavelength 
photons can therefore trigger photo-induced chemical reactions and radical formation, 
resulting in a loss of selectivity for pathogens and in collateral damage for biologics 84. In 
this thesis, we propose a novel strategy to avoid this complication by operating at longer 
wavelengths that do not pose the same risks to biologics. Operation in the near-infrared 
(NIR) is desirable due to greatly reduced molecular absorption.  In this thesis, we 
successfully demonstrate the ability to enhance pathogen inactivation in the NIR regime 
using PEGylated gold nanorods whose localized surface plasmon resonance overlaps with 
800 nm femtosecond pulses.  
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This thesis is a reformatted version of our published manuscripts,85-87 
my contributions to this work includes designing and performing the experiments including 
preparing the optical setup and laser inactivation experiment, spectroscopy, SEM imaging, 
Gel electrophoresis, photoacoustic measurements, preparation of nanoparticle-virus,  
nanoparticle-bacteria and nanoparticle-cell samples, ROS scavengers samples, TEM 
samples and performing the data analysis. I also performed the simulation, helped in 
nanopore measurements, interpreted and analyzed the data. 
Chapter Two introduces the use of plasmonic nanoparticles for near-infrared 
enhancement which leads to photonic viral inactivation.86  We describe a novel inactivation 
approach that takes advantage of the strong light-matter interactions provided by noble 
metal nanostructures that sustain plasmon. We report a plasmonically enhanced virus 
inactivation of Murine Leukemia Virus (MLV) via 10 s laser exposure with 800 nm fs 
pulses through gold nanorods, with LRV>3.7. Importantly, the plasmon-enhanced 
inactivation did not require binding of the NPs to the viruses, the induced inactivation was 
selective to the virus and did not induce any measurable damage to co-incubated 
antibodies. Based on the observations, a model of virus inactivation based on plasmon 
enhanced shockwave generation is proposed. 
 
Chapter Three is a description of the scalability of the plasmonically enhanced pathogen 
inactivation strategy.87 To overcome some of the challenges associated with pulsed laser 
driven pathogen inactivation, we introduce the plasmonic enhancement of photonic 
pathogen inactivation as a possible strategy. We take advantage of the strong light-matter 
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interactions provided by noble metal nanostructures that sustain plasmon and generate high 
local E-field enhancements in electromagnetic hot-spots.88-89 The strong E-field generated 
by the plasmonic nanoparticles can enhance the pathogen inactivation mechanisms. In this 
chapter we test the efficiency of plasmonic enhancement of photonic inactivation using 
resonant gold nanorods (NRs) and bipyramids (BPs) against a diverse group of microbial 
pathogens including non-enveloped viruses (bacteriophage φX174), mollicute bacteria 
(Acholeplasma laidlawii), as well as Gram-negative (Escherichia coli) and Gram-positive 
bacteria (Bacillus subtilis) with 800 nm illumination. This paves the way to a broadband 
photon-driven pathogen inactivation strategy that is selective, efficient, fast and works 
under ambient conditions. 
 
Chapter Four demonstrates our work in the rapid detection of viral inactivation using 
femtosecond laser radiation by measuring the conductance of a solid state nanopore.85 In 
this chapter, we at first investigate the photonic inactivation of the φX174 viruses via 400 
nm laser wavelengths, at multiple treatment times. Then the effect of fs laser on the virus 
in a single virus level is monitored using nanopore technique. By developing a statistical 
model based on the probability distribution function obtained from nanopore data, we 
monitor the survival fraction of viruses with low sample volume, high precision and low 





CHAPTER TWO: Plasmonic enhancement of selective virus inactivation through 
femtosecond laser irradiation 
 
Abstract 
Femtosecond (fs) pulsed laser irradiation techniques have attracted interest as a photonic 
approach for the selective inactivation of virus contaminations in biological samples. 
Conventional pulsed laser approaches require, however, relatively long irradiation times to 
achieve a significant inactivation of virus. In this study, we investigate the enhancement of 
the photonic inactivation of Murine Leukemia Virus (MLV) via 805 nm femtosecond 
pulses through gold nanorods whose localized surface plasmon resonance overlaps with 
the excitation laser. We report a plasmonically enhanced virus inactivation, with greater 
than 3.7-log reduction measured by virus infectivity assays. Reliable virus inactivation was 
obtained for 10 s laser exposure with incident laser powers ≥ 0.3 W. Importantly, the fs-
pulse induced inactivation was selective to the virus and did not induce any measurable 
damage to co-incubated antibodies. The loss in viral infection was associated with reduced 
viral fusion, linking the loss in infectivity with a perturbation of the viral envelope. Based 
on the observations that physical contact between nanorods and virus particles was not 
required for viral inactivation and that reactive oxygen species (ROS) did not participate 
in the detected viral inactivation, a model of virus inactivation based on plasmon enhanced 




Pulsed lasers provide new opportunities for imaging or modulating cellular behavior in 
a diverse range of diagnostic90-91 and therapeutic92  applications. In particular, virus 
inactivation through exposure to ultrashort laser pulses is emerging as a potential 
alternative to existing biocides and ionizing radiation techniques.46, 93-95 The current 
interest in photonic virus inactivation derives from the need for new technologies that 
achieve a selective inactivation of the pathogens in the presence of other biomolecules or 
even living cells in food, feed stock in pharmaceutical bioreactors, therapeutic compounds 
and other sensitive areas with relevance for human and animal health. For many of these 
applications, harsh chemical or ionizing radiation techniques are not appropriate as they 
lack sufficient selectivity. Importantly, Kong-Hon Tsen and coworkers have demonstrated 
in a series of elegant studies that irradiation with femtosecond (fs) laser pulses with visible 
(425 nm)46, 93-96 or near-Infrared (776 nm97-99, 850 nm100) wavelengths results in an 
inactivation of both enveloped and non-enveloped viruses under conditions that do not 
impact mammalian cells.45 Tsen and coworkers postulated that fs laser induced virus 
inactivation is a non-thermal effect that results from impulsive stimulated Raman scattering 
(ISRS) driven breaking of non-covalent bonds in the virus.46, 98 Although individual broken 
contacts can reform, the authors argued that an excessive bond-breaking results in an 
irreversible loss of structural integrity of virus particles46, 93 and potentially in viral protein 
aggregation.94 Theoretical analysis revealed that for ISRS to be effective, high laser 
intensities are required.101 Under these conditions alternative mechanisms to drive 
structural and chemical transformations exist, including multiphoton absorption. It also 
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deserves mentioning that a different group was unable to reproduce the inactivation of 
phages through fs laser irradiation,102 highlighting the need for further research into the 
mechanism of inactivation.  
To date, photonic inactivation was successfully achieved with focused fs laser beams and 
relatively long irradiation times of ≥ 1h.98 The need for long irradiation times limits the 
scalability of the photonic virus inactivation process and impedes the practical 
implementation of photonic virus inactivation strategies in many cases.  
In this manuscript, we explore the plasmonic enhancement of photonic virus inactivation 
as a possible strategy to overcome some of the challenges associated with pulsed laser 
driven virus inactivation. Since noble metal nanoparticles convert incident electromagnetic 
waves into localized charge density oscillations, so called localized surface plasmon 
resonances (LSPRs),88  they generate high local E-field enhancements in electromagnetic 
hot-spots.88-89 The strong E-field generated by the plasmonic nanoparticles can enhance the 
previously discussed virus inactivation mechanisms and, as we show in this manuscript, 
facilitate new virus inactivation processes. We demonstrate that resonant nanoparticles 
whose LSPR overlap with the excitation pulse, enhance the virus inactivation but that non-
resonant nanoparticles have no effect. The effect of resonant plasmonic nanoparticles on 
virus inactivation as function of laser power when irradiated for a short exposure time of 
10 s is characterized in detail. Since both efficiency and selectivity are important figures 
of merit for photonic virus inactivation, we monitored the selectivity towards virus particles 
by measuring the functionality of IgG antibodies co-incubated with the virus particles 
during laser exposure. Our data indicate that the plasmonically enhanced photonic 
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inactivation is highly selective towards virus particles and generates no detectable 
collateral damage to the antibodies, and that the mechanism of inactivation differs from 
those of previously established photocatalytic103 and photothermal104 inactivation methods.  
 
Results and Discussion  
We chose Murine Leukemia Virus (MLV) as target for our viral inactivation studies due 
to its similarity with endogenous mouse retroviruses that are known contaminants in the 
biopharmaceutical industry.105-106 All experiments were performed with a recombinant 
virus that expresses the luciferase reporter gene upon establishment of productive infection 
in target cells, providing a robust strategy for the quantification of virus infectivity. In a 
first set of experiments we tested the hypothesis that nanorods whose LSPR overlaps with 
the incident fs laser pulse enhances the efficacy of light-induced laser activation. To that 
end, we compared the viral infectivity obtained with virus particles exposed to fs laser 
irradiation with constant pulse duration but different average powers. Importantly, we kept 
the exposure time of the individual samples constant at 10 s, which is 3 orders of magnitude 
shorter than the exposure time in all previous photonic virus inactivation studies. Figure 2-
 
Figure 2-1 Schematic of experimental setup for photoacoustic measurements. The following 






1 shows the schematic of experimental setup for photoacoustic measurements of the 
nanorods.  
Nanorods for Viral Inactivation 
The LSPRs of gold nanoparticles are strongly morphology dependent, and the aspect ratio 
of nanorods represents a rational control parameter to tune the plasmon resonance across 
the visible range of the 
electromagnetic spectrum to the 
Near-Infrared (NIR) and beyond.107-
108 We used gold nanorods with an 
aspect ratio of around 4, with typical 
lengths of ~ 60 nm. We found that 
these nanorods sustain a longitudinal 
plasmon mode that peaks close to the 
wavelength of the fs laser emission 
(805 nm) as is shown in the UV-vis 
spectra of the nanorod “control” (no 
laser exposure) in Figure 2-2a. A 
TEM image of a representative 
nanorod is provided as inset. The 
gold nanorods were obtained through 
a surfactant-directed synthesis109 
using  cetrimethylammonium bromide (CTAB) as ligand, which favors growth along the 
 
Figure 2-2 : a) UV-Vis spectra of nanorods recorded 
after 10 s of fs laser irradiation with different average 
powers. Control refers to rods without irradiation. Inset: 
TEM image of nanorod. Size bar = 5 nm. b) Peak 
wavelengths (gray) and widths (black) of the longitudinal 
nanorod plasmon mode as function of the average 




crystallographic [110] axis. Due to the functionalization of the nanorod surface with 
CTAB, the nanorods have a positive zeta-potential of approximately ζ = +23 mV. As 
CTAB is cytotoxic, we replaced it with polyethyleneglycol (PEG) ligands. In a first set of 
experiments we tested the stability of the nanorods when irradiated with 805 nm laser 
pulses with 35 fs duration for 10 s. 
 
Figure 2-3 TEM image of nanorods before (a) and after (b) irradiation with 35 fs laser pulses for 10 
s (average power 3 W). c) Histogram of nanoparticle length before (control) and after laser irradiation. 
d) 2% Agarose gels of rod samples collected before (control) and after laser irradiation with specified 
average powers. The formation of a second band at high laser powers indicates agglomeration. 
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We varied the average laser power between 0.3 W, 1.2 W and 3 W and recorded UV-vis 
spectra after laser irradiation. These spectra and the spectrum of the non-irradiated control 
sample are summarized in Figure 2-2a. The UV-vis spectra contain two characteristic 
peaks. One is centered at 520 nm and is assigned to the transverse plasmon mode of the 
nanorods, whereas the second peak at 800 nm is assigned to the longitudinal plasmon 
mode.107 The peak wavelength of the longitudinal mode intensities and the associated full 
width at half maximum (FWHM), are plotted in Figure 2-2b. Interestingly, we observe a 
blue shift and broadening of the longitudinal mode. These effects are accompanied by a 
decrease in the spectral intensity of the longitudinal mode and an increase in the intensity 
of the transverse mode (Figure 2-2a).  
The observed spectral changes can be attributed to two main effects. Surface melting110-
111 of the nanorods leads to shorter and wider rods with increased oscillator strength for the 
transverse plasmon mode and a blue-shifted longitudinal plasmon resonance. Early studies 
experimentally showed that an average of ~ 60 femtojoule (fJ) energy, which is close to 
our experimental condition, is required to melt a single gold nanorod with an aspect ratio 
~4.112 Figure 2-3a and b shows representative TEM images of nanorods before and after 
laser irradiation with an average power of 3 W, respectively. Visual inspection of the two 
images suggests that after laser irradiation the sample contains significantly more 
spheroidal particles. The histogram of the lengths of the nanorods in Figure 2-3c confirms 
a systematic shortening of the nanorods in response to laser irradiation. The second effect 
contributing to the spectral shift is an agglomeration of the nanorods due to fs laser 
irradiation. Figure 2-3d shows a 2 % agarose gels of nanorods irradiated with different laser 
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powers. At low power, the gel contains only the nanorod band, but for powers ≥ 1.2 W a 
second slower band of dark grey color is detected at the cost of intensity for the original 
nanorod band. This new slower moving band contains agglomerates of nanorods. This 
redistribution of relative intensity from the nanorod band into the agglomeration band 
continues if the average laser power is further increased to 3 W. Agglomeration of nanorods 
leads to the formation of new hybridized plasmon modes that – depending on the geometry 
of the clusters – can be both blue- or red-shifted with regard to the longitudinal mode of 
the individual nanorod. A side-by-side arrangement, for instance, leads to a systematic 
blue-shift in the optically active plasmon mode, whereas end-to-end, T-shape, and off-scale 
side-by-side arrangements yield red-shifts.113 The different spectral responses account for 
the broadening of the plasmon band centered at around 800 nm in the nanorod spectra. The 
observed agglomeration indicates a decomposition of the nanorod surface ligands under 
pulsed laser irradiation that results in a decrease of colloidal stability. 
Although the nanorods show some morphological restructuring and agglomeration, we 
emphasize that both the UV-vis data and the gel studies confirm that the sample still contain 
a substantial fraction of resonant nanorods under the chosen irradiation conditions.  
 
Plasmonically Enhanced Virus Inactivation 
In a typical virus inactivation experiment, PEGylated nanorods were incubated with 
MLV particles in a ratio of more than 10000:1 in a total volume of 67 µL at 4°C for up to 
12 h. The samples were then diluted by adding 933 µL of PBS, pH 7.4 to a total volume of 





Figure 2-4 a) Virus log-reduction-value (LRV) LRV measured for virus (V) and virus + PEGylated 
nanorods (NR) both in the presence of IgG antibody (P) as function of average 805 nm laser power. 
Laser pulse duration was 35 fs. The irradiation time was held constant at t = 10 s. Control = no laser 
irradiation. b) Binding curves for the IgG antibody (P) recovered from the experiments in (a) in the 
presence (red) and absence (black) of nanorods as determined by ELISA. c) LRV obtained for virus 
(V) alone, virus + PEGylated nanorods (NR), virus + annexinV functionalized nanorod (NR+A5) and 
virus + spherical nanoparticles (NP) after irradiation to a pulsed (35 fs) 805 nm laser with an average 
power of 3 W for 10 s exposure time. Inset: TEM image of laser irradiated virus + PEGylated nanorod. 
Size bar = 20 nm. d) Binding curves for antibody (P) irradiated with the pulsed 805 nm laser for 10 s 
at an average power of 3 W as determined by ELISA. Control = no laser irradiation e) LRV obtained 
under similar laser conditions as in (c) but with two-fold increased virus concentration. The increase in 
LRV with virus concentration indicates that the LRV values are limited by the sensitivity of the 
infection assay f) Percentage of viable cells for no-treatment control (mock), cells after incubation with 
a nanorod solution that was not exposed to the laser, and cells treated with a nanorod solution that was 





luciferase encoding recombinant viruses resulted in approximately 1x106 relative light 
units (RLU). We performed the inactivation studies with PEGylated nanorods as well as 
with rods functionalized with annexinV that binds to phosphatidylserine (PS) of the 
enveloped MLV. For the latter, Ca2+ was added to the binding buffer when incubating 
annexinV-functionalized nanorods with virus particles to achieve a final Ca2+ concentration 
of 2 mM. 
In many applications it is necessary to inactivate the virus in a complex biological matrix. 
For instance, virus inactivation plays a critical role in the pharmaceutical industry for the 
fabrication of monoclonal antibodies (mAbs). We emulated realistic process conditions by 
performing the virus inactivation in an IgG antibody (total protein concentration: 160 µM) 
containing Tris solution as biological matrix. The proteins were added after overnight co-
incubation of nanorod and virus.  
In a first set of experiments, we tested the hypothesis that resonant plasmonic nanorods 
enhance fs pulsed laser driven virus inactivation. To that end, virus samples were irradiated 
for 10 s with 805 nm laser pulses with a width of 35 fs in the presence and absence of 
pegylated nanorods. All samples contained IgG antibodies. Figure 2-4a shows the 
measured LRV values for average powers of 0 W (control), 0.06 W, 0.3 W, and 3 W. While 
in the absence of PEGylated nanorods none of these average powers resulted in a 
measurable LRV, after addition of PEGylated nanorods average powers ≥ 0.3 W were 
sufficient to generate a highly significant LRV. A LRV = 1.8 was obtained for an average 
power of 0.3 W and the viral inactivation further enhanced to LRV = 2.6 for an average 
power of 3 W. The striking difference in virus inactivation between samples with and 
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without PEGylated nanorods provides first experimental evidence of a strong enhancement 
of photonic inactivation through PEGylated nanorods. To assess the potential collateral 
damage that laser irradiation has on the co-incubated IgG antibodies, we compared the 
binding of the recovered IgG antibodies to its epitope using ELISA (Figure 2-4b). 
Intriguingly, our ELISA studies revealed essentially identical binding curves for antibodies 
exposed to 0.06 W, 0.3 W, or 3 W of laser irradiation and for the no irradiation control. 
The absence of any laser-induced changes in binding affinity is remarkable and argues 
against any systematic collateral damage during virus inactivation. 
In a second set of experiments, we used the maximum average laser power of 3 W and 
measured viral inactivation in the presence of three different nanoparticles: virus + 
PEGylated nanorods; virus + annexinV-functionalized nanorods; virus + spherical 
nanoparticles. Unlike for the nanorods, the LSPR of the 40 nm diameter gold nanoparticles 
(530 nm) did not overlap with the exciting laser pulse. The nanorod and nanoparticle to 
virus ratios were both higher than 10000:1. Additional controls included laser irradiation 
of viruses without nanoparticles. After laser irradiation for 10 s, virus infectivity was 
quantified (Figure 2-4c). The 805 nm fs laser irradiation had no effect on virus infectivity 
in the absence of nanorods, or upon incubation of virus with spherical nanoparticles whose 
resonance does not overlap with the incident laser pulse. In contrast, addition of PEGylated 
nanorods whose longitudinal mode lies close to 800 nm led again to a strong reduction in 
viral infectivity (LRV~2.7). Interestingly, the LRV value obtained with PEGylated 
nanorods functionalized with annexinV, which can bind to phosphatidylserine (PS) in the 
viral membrane, was not higher than that for the PEGylated nanorods. Since the PEGylated 
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nanorods used in our experiments did not show any systematic cytotoxicity before or after 
laser radiation (Figure 2-4f), we conclude that the decrease in infectivity observed for virus 
samples irradiated with the pulsed laser in the presence of resonant gold nanorods results 
from an enhancement of photonic virus inactivation through resonant plasmonic nanorods. 
We tested for potential collateral damage to IgG antibodies through laser irradiation (3 
W, 10 s) of PEGylated and annexinV functionalized nanorods through ELISA (Figure 2-
4d). This time, the experiments were performed in the absence of the virus. Again, we 
observed essentially identical binding curves for the antibody before and after laser 
irradiation, in the absence or presence of the PEGylated nanorods, respectively (Figure 2-
4d). The antibody binding affinity was not significantly affected by the NIR fs laser 
irradiation of resonant nanoparticles under conditions that achieved a very significant 
inactivation of virus particles.  
One unexpected finding from Figure 2-4c is that annexinV functionalization of the 
nanorods does not yield a stronger reduction of infectivity when compared with the 
PEGylated nanorods. In fact, the PEGylated nanorods without any virus binding 
functionality achieved slightly higher LRV values. To check for non-specific binding of 
PEGylated nanorods to MLV particles we imaged the mix of virus and PEGylated nanorods 
in the TEM (Figure AI-1 of Appendix I). We did not detect any significant spatial 
colocalization between virus particles and PEGylated nanorods, indicating that the non-
specific binding of the PEGylated nanorods to the virus particles is low. A magnified TEM 
image of a virus particle is included as inset in Figure 2-4c. 
The fact that annexinV fails to enhance virus inactivation and the absence of a significant 
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non-specific binding to MLV in the case of the PEGylated nanorods suggests that a direct 
binding between nanorods and virus particles is not required for the nanorod-enhanced 
photonic virus inactivation.  
The LRVs measured in Figure 2-4a and c are limited by a relatively low virus titer, which 
was close to the detection limit of the luciferase activity assay used for the quantification 
of virus infection. Higher LRVs can be achieved by increasing the amount of initial virus 
input in the system. Indeed, when we increased the virus concentration by a factor of 2 and 
used twice as much sample volume for virus infection as before, we measured a LRV = 
3.76 (Figure 2-4e). As our analysis revealed that no binding between nanorod and virus is 
required, we omitted the overnight pre-incubation of virus and PEGylated nanorod for this 
measurement. 
 
Potential Mechanisms of Plasmonic Enhancement 
What is the mechanism underlying the plasmonic enhancement of virus inactivation? 
The fact that the enhancement does not require a physical contact between the nanorod and 
the virus particle argues against field-enhanced ISRS or multiphoton absorption effects as 
underlying mechanisms. Both of these effects are strongly E-field dependent and the E-
field intensity decays rapidly with separation from the nanorod surface. At a distance of 
100 nm, the E-field has already decayed to the value of the incident light field. Considering 
the nanorod concentration used in this work of ~1×1011 particles/mL, which corresponds 
to one rod in a cube of solvent with side length of approximately 2 µm, we can exclude 
that virus particles and nanorods co-localize close enough to generate a sufficient E-field 
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enhancement to impact ISRS or multiphoton absorption of the virus. For similar reasons, 
it is unlikely that thermal effects are the underlying cause of the observed virus inactivation. 
Although the resonant fs laser excitation induces a temperature jump in the nanorod and 
its immediate environment, this effect is local and a subsequent thermalization with the 
heat bath of the solvent rapidly abrogates any temperature gradients. The measured 
temperature fluctuations during the course of our experiments were < 3°C.  
One alternative mode of virus inactivation that does not require direct contact between 
nanorods and virus is the light induced generation of reactive oxygen species (ROS). It has 
been demonstrated in previous studies that plasmon excitation in gold nanocubes can 
generate singlet oxygen (1O2), superoxide anion (O2-), or hydroxyl radical (•OH).114 Even 
if their formation is limited to the immediate vicinity of the nanorods, the ROS can diffuse 
in solution. Singlet oxygen, for instance, has a typical diffusion length in water of 
approximately 200 nm.115 If these reactive species result in the disabling of important 
surface groups required for binding to and uptake into host cells, they could – in principle 
– account for the observed MLV inactivation. To test whether these ROS were involved in 
the virus inactivation, we repeated the fs laser irradiation of a mix of MLV and resonant 
nanorods in the presence of ROS scavengers. In particular, we used sodium azide 
(scavenger for 1O2), MnTBAP (scavenger for O2-), mannitol (scavenger for •OH).116-117 
While the concentration of ROS scavengers used in these experiments did not show any 
cytotoxicity (data not shown), addition of ROS scavengers did not suppress nanorod 
mediated virus inactivation (Figure 2-5a), suggesting that ROS formation mechanism is 
not responsible for the virus inactivation.  
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Another potential virus inactivation mechanism that does not require direct contact 
between the virus and the nanorods is plasmonically-enhanced shockwave generation. The 
duration of the incident pulse is crucial in determining the feasibility of inactivation.118-119 
Intense pressure wave generation is expected to dominate only for very short pulse 
durations as used in this work. We emphasize that although Tsen and coworkers dismissed 
the pressure wave argument in their studies due to insufficient laser power, the situation is 
fundamentally different in our case due to the presence of the plasmonic nanoparticles, 
which we expect to greatly reduce the power threshold for shockwave generation. Based 
on published analyses of threshold intensities in the presence of nanorods,120 we estimate 
that average powers ≥ 0.3 W are sufficient to trigger shockwaves under our experimental 
conditions using pulse durations of 35 fs. We recorded the photoacoustic response of the 
nanorods, which represent a broad band acoustic emissions followed by a gradual 
fluctuation that decreased to near zero until another distinct oscillation arrives (Figure 2-
5b). Although the temporal resolution of our experiments (our transducer was limited to a 
frequency of 2.5 MHz) is insufficient to directly resolve shock waves, the successful 
detection of the acoustic emissions does confirm an efficient transfer of optical energy 
provided by the incident laser to the resonant nanorods. As the shockwave mechanism is 
consistent with all experimental observations, we propose it as underlying mechanism of 
the observed virus inactivation. Future studies with higher temporal resolution will be able 
to shed more light on the shock wave generation and its relevance for MLV inactivation. 
Independent of the exact physical mechanism that causes the plasmonic enhancement of 
virus inactivation, it is key to establish which stage of the viral infection is affected by it. 
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Since TEM inspections after laser exposure did not reveal obvious morphological changes 
in the virus samples, we hypothesized that the effect is primarily caused by molecular-level 
perturbations of the MLV membrane and/or surface groups, which prevents an effective 
binding to the host cell and subsequent fusion. To test this hypothesis, we repeated the fs  
 
Figure 2-5 a) LRV obtained after 10 s irradiation with pulsed 805 nm laser as function of average 
power for virus + ROS scavenger mix (white) and virus + PEGylated nanorod + scavenger mix 
(gray). All samples contained IgG hybridoma (P). The scavenger does not suppress viral 
inactivation.  b) Ultrasonic wave emitted from 0.3 W laser irradiated nanorods recorded by 
photoacoustic transducer.  c) Relative virus fusion (normalized by no treatment control) obtained 
after 10 s irradiation with pulsed 805 nm laser with 3 W. Laser exposure in the presence of nanorods 





laser irradiation of MLV/luc particles containing S15-BlaM fusion protein in presence and 
absence of resonant nanorod. Figure 2-5c shows the normalized virus fusion percentage 
for the virus and a virus-nanorod mixture, without (control) and with laser irradiation at an 
average laser power of 3 W for 10 sec.  The experiments show that only laser irradiation 
in the presence of resonant nanorods achieves a measurable decrease (~2.5-fold) in virus 
fusion. Laser irradiation without nanorods had no measurable effect on fusion. These data 
corroborate the hypothesis that the plasmonically enhanced photonic inactivation primarily 
inactivates viral functions responsible for early stages of the infection, including host cell 
binding and fusion.  
 
Conclusion 
We have demonstrated the enhancement of fs-pulsed NIR radiation induced photonic 
virus inactivation through plasmonic nanoparticles. Irradiation in the presence of resonant 
nanorods significantly reduced viral fusion with the host cell, suggesting that the plasmonic 
enhancement acts on viral surface functionalities responsible for early stages of the viral 
infection rather than on the viral genome or enzymes. LRVs of ≥ 3.7 were achieved with 
MLV in as little as 10 s of irradiation. The inactivation was highly specific to the virus 
while co-incubated IgG antibodies did not show any loss in functionality. The ability to 
enhance the efficacy of selective photonic virus inactivation with NIR radiation through 
plasmonic nanoparticles paves the path to a broader applicability of the technique in 




Materials and Methods 
Laser Set-Up. The ultrashort pulsed (USP) excitation source used in this study is a 
femtosecond laser based upon a Legend Elite Duo (Coherent Inc.) Ti-sapphire regenerative 
amplifier. The laser produces a continuous train of 35 fs pulses at a repetition rate of 1 kHz 
centered at 805 nm with energies up to 7.5 mJ and spectral width of about 25 nm. The laser 
beam was incident on a quartz cuvette containing 250 µL of virus sample. Different laser 
powers on the sample were obtained using beam splitters and directing only a portion of 
the total laser beam to the sample area. The USP laser spot size was approximately 1 cm2 
and the typical exposure time of the sample to the laser irradiation was 10 sec. All laser 
irradiation studies were carried out at 22 °C. After irradiation, the samples were 
immediately stored at 4°C. 
 
Photoacoustic Measurements. The acoustic signal generated by laser irradiated 
nanorods was collected in a homebuilt ultrasound detector. Figure 2-1 depicts the acoustic 
wave measurement setup, based on the design of Yelleswarapu and co-workers.121-123 The 
nanorod sample was placed in a 1 mm quartz cuvette, which was located in a custom cell 
filled with water for ultrasound coupling.  The cuvette was oriented at an angle of 45° 
relative to the 0.3 W fs laser beam. The photoacoustic signal (ultrasonic wave) was 
collected using a 2.25 MHz focused water immersion transducer.   
 
Nanorod Synthesis and Functionalization. We used the seed-mediated growth 
technique described by Vigderman et al to synthesize gold nanorods.124 460 µL of a freshly 
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prepared solution of 0.01 M sodium borohydride dissolved in 0.01 M sodium hydroxide 
was rapidly injected into 10 mL of 0.5 mM HAuCl4 solution containing 0.1 M CTAB under 
extensive stirring. A change of color from greenish to light brown indicated the successful 
formation of gold nanoparticle seeds. To synthesize gold nanorods with a longitudinal 
resonance at ~ 800 nm, 11.5 µL of 0.1 M silver nitrate solution was added to 10 mL of 0.5 
mM HAuCl4 solution containing 0.1 M CTAB. Subsequently, 500 µL of 0.1 M aqueous 
hydroquinone solution was added, and the resulting mixture was hand-stirred until it 
became clear. Then, 160 µL of gold seed solution was added under thorough stirring. The 
resulting mix was allowed to age overnight. To obtain PEGylated nanorods, 2.5 µL of 10 
mM PEG2 (HS–CH2CH2–(C2H4O)77–N3) were added together with 2.5 µL of 10 mM HS-
(CH2)11-(CH2CH2O)6OCH2-COOH to 1mL of gold nanorods in the presence of 3% v/v of 
Tween® 20. The samples were incubated overnight and washed by centrifugation and 
subsequent resuspension. Alkyne-functionalized annexinV was cross-linked to the azide 
functionalized nanorods in the presence of 500 µM ascorbic acid and 100 µM CuSO4 via 
CuI catalyzed click-reaction125. The nanorods were cleaned again through repeated 
centrifugation and resuspension in DDI water or buffer.  
  
Cells and Virus Production.  HEK293T and Rat-2 cells were maintained in DMEM 
supplemented with heat-inactivated 10% fetal bovine serum (Invitrogen) and Pen/Strep 
(HyClone). Luciferase expressing, single cycle of replication competent MLV particles 
(MLV/luc) were derived via co-transfection of HEK293T cells with pLNC-luc (luciferase 
expressing retroviral expression vector) and pCL-Eco (MLV packaging vector that 
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expresses MLV Gag, Pol and ecotropic Env glycoproteins; Imgenex) plasmids, as 
previously described.126 For the virus fusion assay described below, HEK293T cells were 
co-transfected with pLNC-luc, pCL-Eco and S15-BlaM plasmids. To generate the S15-
BlaM expression plasmid that expresses a Src-epitope tagged β-lactamase fusion protein 
upon transfection, the N-terminal 15 amino acid sequence of c-Src (S15) was cloned in 
frame upstream of β-lactamase orf in pcDNA3.1/zeo+ (Invitrogen) eukaryotic expression 
plasmid. S15-BlaM is incorporated into MLV particles upon virus particle budding from 
the plasma membrane of virus-producing cells.127,128 Virus-containing supernatants were 
harvested 2 days post transfection, and passed through 0.45 µm filters. Virus was 
concentrated by ultracentrifugation on a 20% sucrose cushion [28,000 rpm at 4˚C for 2 
hours with a SW32 Ti rotor (Beckman Coulter)]. Virus pellets were resuspended in PBS, 
aliquoted, and stored at -80 °C until further use.  
 
Preparation of Nanorod-Virus Samples. PEGylated nanorods or nanorods loaded with 
annexinV were centrifuged at 5000 rpm for 10 min. The supernatant was discarded and 17 
µL of the pellet was added to 50 µL of MLV/luc, followed by overnight incubation at 4°C. 
Then, 500 µL of IgG antibody (anti-p24gag monoclonal antibody; Clone 183-H12-5C; NIH 
AIDS Research and Reference Reagent Program, contributed by Dr. Bruce Chesebro) in 
RPMI medium was added to the mixture and the mixture was diluted by adding 1x Tris 
(pH 7) or PBS (pH 7.4) buffer to final volume of 1 ml. The nanorod to virus ratio was more 
than 10000:1. The concentration of the nanorods was quantified using a UV-vis 
spectrometer (Cary 5000 spectrophotometer). 
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ROS Scavengers. A solution containing three different ROS scavengers were used. 
Sodium azide (NaN3) and Manitol were dissolved in 20 mM Tris (pH 7.0). Then 
Manganese (III) Tetrakis (4-benzoic acid) Porphyrin (MnTBAP) dissolved in 0.1 M NaOH 
was added. This solution was subsequently added to virus samples containing antibodies 
from a hybridoma preparation or to mixtures containing virus, PEGylated nanorods, and 
antibodies. All samples were diluted with Tris buffer. The final scavenger concentrations 
were 10 mM Manitol, 10 mM Sodium azide and 0.02 mM MnTBAP. The pH of the final 
solution was 7.  
 
ELISA. To test the efficacy of the fs laser inactivation protocol on functionality (epitope 
recognition) of a monoclonal antibody, an anti-p24gag monoclonal antibody was exposed 
in the presence or absence of MLV/luc particles to fs laser, as described above. A sandwich 
ELISA was performed to test the ability of the anti-p24gag monoclonal antibody to quantify 
standard amounts of HIV-1 p24gag antigen, as described previously.129 Briefly, 2-fold 
dilutions of p24gag antigen (ABI, Inc) was bound to HIV-Ig (NIH AIDS Research and 
Reference Reagent Program, contributed by NABI and National Heart Lung and Blood 
Institute, Dr. Luiz Barbosa) coated wells and detected with unexposed control or laser 
exposed anti-p24gag monoclonal antibody, and HRP-conjugated goat anti-mouse secondary 
antibody (Sigma). ELISA was developed with a peroxidase substrate (KPL, Inc) and the 
standard curves were generated with each of the control (untreated) or fs laser-exposed 




Virus Fusion Assay. To investigate MLV/luc fusion to Rat2 target cells, a FACS based 
assay130 was utilized with some modification. Briefly, untreated or laser-exposed MLV/luc 
particles containing S15-BlaM fusion protein was used to infect target cells. After 
incubating 2 hours at 37˚C, cells were washed with CO2-independent media (Invitrogen) 
and incubated in CCF2 (fluorogenic substrate of β-lactamase)-containing media at 18˚C 
over night, washed, fixed with 4% PFA. The number of β-lactamase positive cells was 
determined by FACS analysis using a LSRII flow cytometer (BD). 
 
Quantification of Virus Inactivation. Virus inactivation was determined by infecting 
cells (mouse fibroblast cell line) with treated (laser-inactivated) or untreated viruses. Cells 
were then incubated for 48 h prior to lysis. The lysates were then used for measurement of 
luciferase activity using a chemiluminescent reporter (Bright-Glo, Promega). The ratio of 
the intensity of the luminescence to a calibration standard is measured in RLU 
(relative light units), and is a linear function of the reporter concentration. If RLU-  and 
RLU.   are the measured RLU values of the control and sample respectively, the Log-
Reduction Value (LRV) defined as LRV = log4((RLU-/	RLU.)  gives a quantitative 
measure of the extent of virus infection in the culture. 
 
Quantification of Cell viability. In order to test for potential cytotoxicity of nanorods, 
laser irradiated and non-irradiated nanorods media were harvested and incubated with Rat-
2 cells at 37˚C overnight. The Trypan blue exclusion test was then used to determine the 
percentage of viable cells. 
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Gel Electrophoresis of Nanorods. Nanorod samples were run on 2% agarose gels made 
from 0.5x TBE. The same buffer was used as running buffer. The samples were loaded 
with ficol and were run with a current of 200 mA, voltage of 140 V for 30 min. 
 
Statistical Analysis. The variability in the data was analyzed by ANOVA with 
subsequent post-hoc test as implemented in Matlab. Differences between samples with a 
significance level of P < 0.05 are marked with one asterisk (*), and for P < 0.01 with two 
asterisks (**). NS was used to mark non-significant differences.  
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CHAPTER THREE: Plasmon-Enhanced Pan-Microbial Pathogen Inactivation in 
the Cavitation Regime: Selectivity Without Targeting 
 
Abstract 
Pan-microbial inactivation technologies that do not require high temperatures, reactive 
chemical compounds, or UV radiation could address gaps in current infection control 
strategies and provide efficient sterilization of biologics in the biotechnological industry. 
Here, we demonstrate that femtosecond (fs) laser irradiation of resonant gold nanoparticles 
(NPs) under conditions that allow for E-field mediated cavitation and shockwave 
generation achieve an efficient plasmon-enhanced photonic microbial pathogen 
inactivation. We demonstrate that this NP-enhanced, physical inactivation approach is 
effective against a diverse group of pathogens, including both enveloped and non-
enveloped viruses, and a variety of bacteria and mycoplasma. Photonic inactivation is 
wavelength dependent and in the absence of plasmonic enhancement from NPs, negligible 
levels of microbial inactivation are observed in the near-infrared (NIR) at 800 nm. This 
changes upon addition of resonant plasmonic NPs, which provide a strong enhancement of 
inactivation of viral and bacterial contaminants. Importantly, the plasmon-enhanced 800 
nm femtosecond (fs)-pulse induced inactivation was selective to pathogens and was 
obtained without specific targeting of the NPs to the pathogens. No measurable damage 






The alarming growth of antibiotic resistances and hospital associated microbial 
infections is driving an urgent general need for alternative microbial inactivation strategies 
in the entire health care sector.  Although less publicized than the challenges associated 
with treating human infections with resistant pathogens, the need for new pathogen 
inactivation strategies also applies to key sectors of biotechnology that rely on mammalian 
cell and tissue culturing. Of particular importance to the pharmaceutical industry sector is 
the need to safely produce biologics, which are one of the fastest growing classes of 
pharmaceuticals with high direct relevance for human health. Some biologics, such as 
monoclonal antibodies (MABs), are fabricated with living mammalian cells, rendering 
them particularly vulnerable to contaminations by microbes and pathogens. Microbial 
contaminations cause changes in the composition of the bioreactor used to manufacture 
biologics, potentially inducing a loss in the potency due to degradation, and can by 
themselves be harmful for human health. Aseptic processing of a biopharmaceutical 
process is often insufficient, so a terminal sterilization for biologics is mandatory. 28-29, 131 
Since microbe inactivation through high temperatures, 32 UV irradiation 33-34 or aggressive 
chemicals risk a deactivation of the precious biologics, alternative inactivation and removal 
strategies of viruses, 3 mycoplasma, 4 and bacteria 37 are needed in the pharmaceutical 
industry. The current best practice for final viral clearance is passive filtration. 30 Filtration 
is also the preferred method to remove bacterial contaminations, including mycoplasma. 
The latter are small bacteria that lack a cell wall. 132 Mycoplasma are not only detrimental 
to human health, with some species being pathogenic, 133 but they are also widespread 
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contaminants of cell culture. 35 A key challenge for viral and mycoplasma clearance of cell 
culture by filtration is the small size of the organisms. Mycoplasma can pass through 200 
nm filter pores and the filter size requirements are even more stringent for viruses. For 
instance, parvovirus is a truly nanoscale object with a characteristic diameter between 18-
26 nm. 36 These very small sizes pose significant challenges for a reliable removal of 
pathogen contaminants with conventional nano-filtration devices.  
A potential alternative to filtration that has recently attracted interest is sterilization with 
pulsed laser sources. The groups of Tsen and Achilefu have shown that femtosecond (fs) 
lasers can inactivate enveloped viruses, non-enveloped viruses, bacteria, and yeast in a 
label-free manner. 38 The authors argued that virus inactivation was primarily due to 
impulsive stimulated Raman scattering, although this interpretation has been challenged. 
134 Limitations of the conventional pulsed laser pathogen inactivation method include the 
requirement for long exposure times that limit the scalability of the approach and the 
predominant use of near-UV lasers. In the published studies, 46, 48 samples were typically 
irradiated for ≥1 hour with fs laser pulses at a wavelength of λ= 415±5 nm.  A significant 
concern associated with exposing biological samples to short wavelength radiation, 
especially pulsed laser radiation, is that photon energies overlap with electronic transitions 
in biomolecules (DNA, RNA, proteins). Absorption of short wavelength photons can 
therefore trigger photo-induced chemical reactions and radical formation, resulting in a 
loss of selectivity for pathogens and in collateral damage for biologics. 84 These UV-
absorption driven mechanisms could play a significant role in the previously observed virus 
inactivation. One possible strategy to avoid this complication is to operate at longer 
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wavelengths that do not pose the same risks to biologics. Operation in the near-infrared 
(NIR) is desirable due to greatly reduced molecular absorption, and photonic virus 
inactivation in the NIR has indeed been successfully demonstrated, but unfortunately the 
need for long exposure times which limits the scalability of this technique has remained. 39 
There has recently been significant interest in the nanoscale plasma generation around 
plasmonic nanoparticles (NPs) and it was concluded that under fs-pulsed laser irradiation 
the intense field surrounding plasmonic NPs induces cavitation, which can trigger 
hydrodynamic shockwaves. 61-63 We discovered that the photonic inactivation of 
membrane-wrapped murine leukemia virus (MLV) using pulsed NIR lasers can be 
drastically improved if the virus is irradiated in the presence of NPs in the regime of 
shockwave generation. 86 We demonstrated that the ultrashort pulsed laser technology 
facilitates a rapid and effective inactivation of viruses in the presence of plasmonic NPs. 
Importantly, the plasmon-enhanced inactivation did not require binding of the NPs to the 
viral pathogens and was selective to the virus and did not induce any measurable damage 
to co-incubated antibodies. 86 
As real-world samples risk contamination by a wide range of potential microbes, 
including enveloped and non-enveloped viruses, as well as Gram-positive or Gram-
negative bacteria and mollicute bacteria (i.e. mycoplasma), it remains a high priority to 
develop efficient inactivation strategies that can reliably inactivate biologically-diverse 
pathogens. Conventional photonic inactivation has been primarily investigated with 
different virus species as target pathogens. Only a few studies have investigated the 
feasibility of de-activating bacterial pathogens, such as E. coli, S. typhi, L. monocytogenes 
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and, E. sakazakii 45-46.  Lu et al. 47 report that E. coli bacteria could be inactivated by up to 
3 LRV through irradiation with ultrashort 415 nm light pulses using a laser power density 
of 3.5 GW/cm2 for 1 h. The authors attributed the inactivation to the density dependent 
protein aggregation induced by the visible pulsed laser irradiation. 47 Tsen et al. 38 found 
that gram-negative bacteria such as E. coli and S. typhimurium and Gram-positive bacteria 
such as Listeria could be inactivated by LRV of 2.4, 3.1, and 2.4 , respectively, upon 
irradiation with a 100 fs laser working at 415±5 nm for 1.5 h. Furthermore, until today 
there has only been a very limited number of studies into the photonic inactivation of 
mycoplasma with ultrafast lasers. Tsen et al. 48 focused on A. laidlawii and M. orale for 
which they demonstrated a reduction in viability through pulsed laser irradiation of only 
~2 LRV. Overall, the level of inactivation obtained for bacteria and mycoplasma with 
photonic inactivation strategies remains insufficient for clearance purposes and motivates 
the development of improved enhancement strategies for these pathogens. NPs of different 
chemical composition provide opportunities for the development of new antimicrobial 
strategies with potentially pan-microbial efficacy. 135-138 Gold NPs are of interest for 
different therapeutic applications due to their biocompatibility, easy surface modification 
and plasmon absorption in NIR regions.  Different efficient broadband gold plasmonic 
nanostructures 58-60 exist that can generate high local E-field enhancements in 
electromagnetic hot-spots. In this work, we focus on the photonic inactivation of pathogens 
enhanced by resonant gold nanorods (NRs) and bipyramids (BPs) and test the efficacy of 
the plasmon-enhanced photonic inactivation strategy against a diverse group of microbial 
pathogens. Plasmonic NRs and BPs act as efficient nanoantennas that concentrate the 
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incident electromagnetic radiation into their near-field, and we hypothesize that the 
associated strong fields are responsible for inducing a cavitation phenomenon. This 
hypothesis is justified by previous reports of nanoscale bubble generation through field-
driven photoionization and photoexcitation of a free-electron plasma in the immediate 
vicinity of noble metal NPs in solution. 139-143 In this work we demonstrate that plasmonic 
enhancement of photonic inactivation is successful in eliminating non-enveloped viruses 
(bacteriophage φX174), mollicute bacteria (Acholeplasma laidlawii), as well as Gram-
negative (Escherichia coli) and Gram-positive bacteria (Bacillus subtilis). Importantly, the 
plasmonic enhancement facilitates a reduction in illumination time at 800 nm, which paves 
the path to a broadband photon-driven pathogen inactivation strategy that is fast, selective 
and works under ambient conditions.  
 
Results and Discussion 
To demonstrate the efficacy of plasmonic enhancement of photonic inactivation of 
pathogens, we chose an operational wavelength in the NIR (800 nm). We chose this 
wavelength region as linear electronic or vibrational absorption cross-sections of 
biomolecules are small, and direct lowest order interactions between photons and 
biological matter is therefore minimal. A variety of nonlinear multiphoton processes can 
occur. Two-photon processes, 144 for instance, include primarily the electronic excitation 
of heme in proteins such as cytochrome C with a cross-section of < 1 GM (= 10-50 cm4 s 
molecules-1 photon-1). 145 The subsequent rapid non-radiative relaxation leads to heating of 
< 1 K at the concentration of cytochromes expected. At 800 nm, three-photon processes 
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can in principle excite electronic transitions in DNA or in water, but the cross-sections are 
too low for 3-photon pathogen inactivation. Raman and inelastic processes can result in 
transfer of energy but the cross-sections of ~ 10-31 cm2 at 800 nm are too low for concern. 
Resonance Raman processes can generally be neglected at the fundamental 800 nm. The 
magnitudes of the electric fields in the laser are below the dielectric breakdown in water 
146. In summary, effects attributed to direct molecular absorption at 800 nm are too small 
to account for the observed pathogen inactivation. In contrast, gold NPs can sustain strong 
plasmon resonances in the NIR. Our experimental strategy is to utilize the resonant 
excitation of localized plasmon resonances to generate intense local fields around the NPs 
that initiate cavitation and subsequent shockwave generation under high power pulsed laser 
irradiation. 146 Specifically, we used two different NP geometries with localized surface 
plasmon resonances (LSPRs) at or close to 800 nm in this work: NRs with an aspect ratio 
of around 4 and typical lengths of ~60 nm, and BPs with a length of 81.7 ± 1.6 nm, width 
of 27.5 ± 0.6 nm and tip radius of ~ 4 nm. The advantage of the gold BPs is that they can 
be generated with less structural variability on the ensemble level, which leads to sharper 
initial LSPR spectra. 147  
As the intense pulsed fs-laser irradiation induces a surface melting of the BPs, we 
characterized the morphological changes to determine the optimal operational conditions. 
To that end, we irradiated BPs with 800 nm laser pulses with 35 fs duration and 3 W 
average power for different time durations: 10 s and 1, 10 and 30 min. We recorded UV-
vis spectra and TEM images after laser irradiation. Figure 3-1 illustrates the gradual 
conversion of BPs into spheres. The structural reshaping is associated with a loss in 
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oscillator strength and broadening for the longitudinal plasmon mode at 800 nm, while the 
increase at 520 nm (slightly red-shifted from the vertical mode of the BPs) results from an 
increase in spheroidal particles. Since the plasmon-mediated enhancement of photonic 
pathogen inactivation is a resonant effect, 86 and the LSPR wavelength of the generated 
spherical gold NPs does not overlap with the preferred pump wavelength of 800 nm, we 
limited the maximum exposure time in this work to 20 min for Bacillus subtilis (B. subtilis) 
or 30 min for Acholeplasma laidlawii (A. laidlawii) and Escherichia coli (E. coli). We used 
both NRs and BPs in a ratio of approximately 100:1 (NP: pathogen) in this work and did 
not detect a significant difference in pathogen inactivation between the two forms of 
plasmonic resonators.  
 
Figure 3-1 The interaction of an ultrafast laser irradiation with plasmonic bipyramids. (A) UV-Vis 
spectra of bipyramids recorded after irradiation of the sample with 800 nm fs laser with 3W power for 
different irradiation time. Control refers to bipyramids without irradiation. TEM image of bipyramids 




Wavelength Dependence of Photonic Inactivation of Bacteriaphage, φX174  
A previous study demonstrated the fundamental feasibility of a plasmonic enhancement 
of pulsed laser photonic inactivation of viral pathogens, but that work was limited to the 
enveloped virus MLV. 86To confirm a broader relevance and, in particular, to demonstrate 
the efficacy of plasmon-enhanced photonic inactivation of viruses that are not membrane-
wrapped and therefore more robust, we studied inactivation of the bacteriophage φX174, 
which is arguably one of the most robust virus species. 148 We first determined the log-
reduction value (LRV) of batch mode processing for a solution containing 2 mL of φX174 
in the absence of gold NRs using either the fundamental (~800 nm) output or the frequency 
doubled (~400 nm) output (Figure 3-2A). Previous studies utilizing 100 fs near-UV (415 
nm) pulses, reported effective viral inactivation (Figure 3-2B) for power densities greater 
than ~20 MW/cm2,149 and we achieved a reproducible reduction in φX174 concentration 
using frequency-doubled 400 nm fs laser pulses with just 1 min of exposure. 85 In contrast, 
at 800 nm we found only modest LRV after 15 min exposure to 35 fs long pulses with 
power densities beyond 100 GW/cm2 and remarkably almost into the TW/cm2 scale. Even 
longer exposure times of up to 120 min with 800 nm pulses did not achieve a substantial 
improvement of φX174 inactivation. Importantly, a comparison of LRV obtained at 
fundamental (red) and frequency doubled (blue) wavelengths for different irradiation times 
(Figure 3-2C) shows that the long wavelength has a much smaller effect. This finding 
resolves one part of the contention in the published literature. 134 Our results demonstrate 
that 800 nm ultrashort laser pulses – even at GW/cm2 power densities – do not provide a 
sufficiently strong effect to inactivate viruses. Turning to the effect of frequency-doubled 
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~400 nm centered laser pulses, however, short exposures of less than 1 min are sufficient 
to inactivate viruses to a point where it is difficult to detect virus at all in initial titers of ~ 
106 plaque forming units (pfu)/mL. We subsequently performed experiments at still higher 
initial titer ranging up to 109 pfu/mL. The higher titer allowed for a greater dynamic range 
in the virus inactivation assays. Under these conditions laser exposure studies indicate an 
LRV of greater than 6 (Figure 3-2C), exceeding the industry guidelines of LRV > 4 for 




Figure 3-2 Ultrafast laser treatment of viruses in batch mode. (A) Schematic of experimental setup 
for photonic pathogen inactivation in batch mode. The following abbreviation are used; fs: 
femtosecond, BBO: Beta barium borate.  (B) Log reduction value (LRV) for MNV-1 derived from 
the literature 150 and for φX174 obtained by us. Our work clearly shows a wavelength dependent 
difference in the LRV in φX174. At high virus titer, an LRV of > 6 was achieved which indicates 
that the LRV values are limited by the sensitivity of the infection assay. (C) Demonstration of viral 
inactivation with laser treatment shows consistent LRV of > 4, even for the shortest ~ 1min exposure 
times when exposed with frequency doubled 400nm (Blue). Little or no reduction was detected with 
800 nm laser (Red) radiation, even with incident intensities > 100 GW/cm2.  
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Photonic Inactivation of φX174 in Flow-through Mode 
A current bottleneck of photonic inactivation strategies is insufficient experimental 
throughput. One possible strategy to treat larger volumes of cell medium is based on a 
flow-through approach in which a continuous flow passes through the laser beam (Figure 
3-3A), allowing to avoid any wait times or process interruptions. Figure 3-3B shows the 
results of femtosecond laser inactivation of φX174 with 109 pfu/mL using frequency 
doubled femtosecond laser pulses as well as of controls. In the flow-through mode 
geometry, a solution containing 2 mL of φX174 virus is continuously pumped with a flow 
rate of 2 mL/h through a 2 mm cuvette at an effective filtrate flux of 111 L/h/m2. The 
cuvette is irradiated with frequency-doubled 400 nm pulsed laser irradiation. The 
experiments do not involve stirring and the flow rates were sufficiently slow to ensure 
laminar flow throughout the experiment. Our measurements yield more than 5.8 LRV 
reduction in the laser exposed samples. Controls include samples with no laser exposure 
held in the refrigerator and “No Laser” samples that experienced the same experimental 
condition as the laser exposed sample but without laser irradiation. Importantly, both of 
these controls did not show virus inactivation, with an upper limit on the LRV that is nearly 
5 orders of magnitude smaller than with the laser on. We also determined LRV of laser 
irradiated virus sample without freezing the virus after the laser exposure but before the 
plaque assay. These measurements yielded LRV of ~ 6, which suggests that the freeze-
thaw cycle of the sample after each experiment does not significantly damage the virus. 
The robust inactivation in the flow-through mode by frequency-doubled femtosecond near-
UV laser pulses confirms the results obtained in the batch mode. To check for scalability 
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of the flow-through technique, the total volume of the sample was varied from 2 mL to 5 
mL with a constant flow rate of 2 mL/h. For all of these samples similar laser-dependent 
reductions in infectivity were observed.  
 
Plasmonic Enhancement of φX174 Inactivation 
The lack of a significant reduction in viral load with 800 nm fs-pulsed laser irradiation 
(Figure 3-2C) is indicative of a greatly reduced propensity for photo-damage through single 
 
Figure 3-3 Plasmon-enhanced treatment of viruses in flow-through mode. (A) Schematic of 
experimental setup for pathogen inactivation in flow-through mode. (B) φX174 (V) log-reduction-value 
in the flow-through mode demonstrates effective viral inactivation with LRV of > 6 using frequency 
doubled 400 nm laser treatment, which is independent of sample volumes or freezing step after 
experiments before the assay. Laser average power was held constant at 2.5 W and flow rate of 2mL/h 
(C) LRV measured for φX174, φX174+ PEGylated nanorods (NR), φX174+ PEGylated bipyramids 
(BP) in flow- through mode with 2ml/h flow rate when exposed with 800 nm laser.  LRV also obtained 
for φX174+ PEGylated nanorods, under similar laser conditions but for flow rate of 100 mL/h.  Laser 




photon absorption processes in the IR. The fact that only pulsed 400 nm but not 800 nm 
light achieves a measurable inactivation of φX174 limits the applicability and usefulness 
of the conventional photonic virus inactivation strategy as significant collateral damage on 
precious molecules and biologics in the solution can be expected for an operational 
wavelength in the near-UV. At 800 nm, the risk of collateral damage is much lower 86 as 
linear electronic or vibrational absorption cross-sections of biomolecules are negligible and 
direct lowest order interactions between photons and biological matter is at a minimum. 
Three-photon processes could in principle excite electronic transitions in DNA or in water, 
but the cross-sections are exceedingly low. Furthermore, Raman and inelastic processes 
can result in transfer of energy, but the cross-sections of ~ 10-31 cm2 at 800 nm are still too 
low for concern. Resonance Raman processes can generally be neglected at the 800 nm 
fundamental due to a lack of accessible electronic excited states at this energy. In summary, 
effects attributed to molecular absorption at 800 nm are too small to account for an efficient 
pathogen inactivation. The challenge is, thus, to develop enhancement strategies that allow 
a selective photonic inactivation of the targeted pathogens under NIR irradiation and that 
can simultaneously take advantage of the overall low collateral damage at long 
wavelengths. While intrinsic molecular absorption is weak in the NIR, metal NPs have 
shape-tunable optical cross-section and can provide absorption optical cross-sections of 
~10-10 cm2 at 800 nm. 151 Importantly, although the electric field intensities of the laser 
used in this study are below the threshold for dielectric breakdown in water, 146 this changes 
in the presence of plasmonic nanoantennas that can focus the incident light power into 
nanoscale “hot-spots”. Photonic excitation of surface plasmons in NPs exhibit an 
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extraordinarily rich variety of phenomena. Depending on the pulse width, intensity and 
center frequency, reported effects range from photothermal effects, nonlinear photonic 
effects, and release of reactive oxygen species, among others. 63, 152   Photoacoustic signals  
detected  in previous studies on plasmon-enhanced inactivation of viruses using 
femtosecond lasers are consistent with a plasmonic cavitation induced shockwave as 
potential mechanism of MLV viral inactivation. 86 To evaluate whether the same 
mechanisms applied to other, non-enveloped viruses, we tested the effect of gold NRs on 
the inactivation of φX174 at 800 nm in a flow-through geometry with a flow rate of 2 mL/h. 
Intriguingly, when we irradiated φX174 with initial titer of 109 pfu/mL and a sample 
volume of 1.5 mL at 800 nm with 3W laser power in the presence of resonant gold NRs or 
BPs, we obtained a very impressive LRV of > 7 (Figure 3-3C). A control without gold NRs 
achieved only a LRV of ~1.3 under identical conditions. We mention in passing that when 
we increased the flow to 100 mL/h, corresponding to a reduction in the laser exposure time 
to less than 1 min, the measured LRV in the presence of the NRs dropped to 2.9, confirming 
that the inactivation observed with the NRs is a photonic effect. Previous studies 
demonstrated that when plasmonic NPs are irradiated by a pulsed laser, a rapid phase 
transition occurs in the surrounding liquid which leads to nanobubble generation around 
the NPs. The quick expansion and collapse of these nanobubbles, can generate strong 
pressure waves. 153-154 Under our experimental condition, the strong field localization 
provided by NRs and BPs is responsible for efficient transduction of photons to 
hydrodynamic waves, 86 which we hypothesize enables shockwave-induced mechanical 
damage to the investigated pathogens.   
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800 nm Laser Irradiation Does Not Result in Protein Collateral Damage 
 To assess the effect of pulsed fs irradiation on the structure of proteins, we exposed the 
monoclonal antibody at high concentration of ~38 mg/mL to 800 nm fs radiation and 
frequency-doubled 400 nm laser pulses for 10 s, 1 min and 5 min and analyzed structural 
changes to a monoclonal antibody induced fs-irradiation in batch mode (Figure 3-4). 
Changes in the cation exchange and size exclusion chromatography of the antibody after 
irradiation at 400 nm indicate structural modifications in this case. Importantly, no 
evidence for structural changes or agglomeration or UV-vis absorption spectrum change 
 
Figure 3-4 Characterization of monoclonal antibodies after laser exposure. (A) Cation exchange 
chromatograms, (B) Aggregate and monomer ratios determined by size exclusion chromatography, (C) 
UV-Vis spectra of antibodies recorded after 0-300s fs- laser irradiation with red (left) and blue (right) 
light. No significant changes in spectrum is observed. 
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were observed for samples irradiated at 800 nm. These data, together with the previous 
finding that pulsed 800 nm irradiation does not reduce antibody binding to its epitope in 
the presence of NRs 86 demonstrate an exquisite selectivity of the plasmon-enhanced 
inactivation process at a wavelength of 800 nm that selectively inactivates virus but does 
not induce functional or structural damage on antibodies.  
 
Plasmonic Enhancement of Photonic Inactivation of Bacteria and Mycoplasma 
We first evaluated whether the photonic inactivation of mycoplasma can be 
plasmonically enhanced. We chose mycoplasma A. laidlawii in media for these studies 
since it is one of the most frequent culture contaminations for cell and tissue cultures. 155 
We exposed A. laidlawii (~2x109 CFU/mL) for 30 min with 35 fs 800 nm pulses in the 
presence and absence PEGylated NRs and frequency doubled 400 nm radiation. 800 nm 
irradiation without plasmonic enhancement did not yield a significant mycoplasma 
inactivation but frequency doubled 400 nm irradiation achieved a LRV of 2.9 (Figure 3-
5A). Intriguingly, addition of resonant PEGylated NRs in solution yielded an impressive 
LRV = 6.7 (complete kill). Resonant NRs successfully amplified the photonic inactivation 
of A. laidlawii. These intriguing findings underline the applicability of the plasmonic 
inactivation enhancement approach for a diverse groups of pathogen species.  
Mycoplasma differ from other Gram-negative and Gram-positive bacteria through the 
lack of a cell wall. The absence of a cell wall and the associated structural flexibility 
complicates removal of mycoplasma through filtration but, at the same time, may make 
this bacteria genus more susceptible to shockwaves generated through pulsed laser 
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excitation of resonant gold NPs. In the next step, we therefore tested the hypothesis that fs 
laser irradiation in the presence of gold NPs can boost the inactivation of Gram-negative 
(E. coli) and Gram-positive (B. subtilis) bacteria. We found for both species a significant 
inactivation enhancement in the presence of NRs. The measured LRV for B. subtilis (~109 
CFU/mL) in Figure 3-5B was 3.4, which compares with -0.25 for 20 min 100 fs-laser 
irradiation only (without resonant gold NRs). The fact that bacteria grow in the absence of 
NRs over the course of the experiment leads to small negative LRV values. For E. coli 
(~109 CFU/mL) we measured a LRV of 4.7 after irradiating the bacteria for 30 min with  
800 nm 100 fs laser pulses in the presence of gold NRs (Figure 3-5C).  Interestingly, these 
 
Figure 3-5 Plasmonic enhancement of photonic inactivation of mycoplasma, B. Subtilis and E. coli.. 
(A) LRV obtained after 30 min irradiation of A. laidlawii (Bac.) with pulsed (35 fs) 800 nm laser (Red), 
frequency doubled 400 nm laser (Blue) in the presence and absence PEGylated gold nanorods (NR) (B) 
LRV obtained after irradiation to a pulsed (100 fs) 800 nm laser with an average power of 3 W for B. 
subtilis (Bac.) alone and B. subtilis + PEGylated nanorods (Bac.+NR). Irradiation time was 20 min. (C) 
LRV of E. coli in absence (Bac.) and presence (B+NR) of PEGylated NR. under similar laser conditions 
as in (B) but with 30 min irradiation time. (D) SEM image of E.coli bacteria (control) incubated with 
PEGylated NR. Size bar = 1 µm.  
 
59 
high reduction values are achieved with PEGylated NRs that do not have any pathogen 
binding functionality. To test for potential nonspecific binding of PEGylated NRs to E.coli, 
we imaged the mix of E.coli and PEGylated NRs via scanning electron microscopy (SEM). 
We did not detect any significant spatial colocalization between bacteria and PEGylated 
NRs (Figure 3-5D). The fact that the nonspecific binding of the PEGylated NRs to the 
pathogen is low corroborates the hypothesis that direct binding between NPs and pathogens 
is not needed to achieve efficient inactivation with fs-irradiated NRs. 86 
 
No Collateral Damage to Chinese Hamster Ovary (CHO) cells through NR Treatment 
To check the effect of pulsed fs irradiation on the viability of mammalian cells in the 
presence of resonant NRs, we quantified the effect of NRs and NR + pulsed laser irradiation 
on the viability of Chinese hamster ovary (CHO) cells.  First to check the collateral damage 
of NR treatment, 1.5 mL of CHO cells (~2x107 cells/mL) were incubated with more than 
1000-fold excess gold NRs for 30 min. The changes in the viability of CHO cells were 
quantified with Trypan Blue (Figure 3-6), and the results do not indicate any cytotoxicity of 
the NRs. Intriguingly, even after irradiating these mammalian cells with 100 fs 800 nm 





In summary, we have found experimental evidence that NPs under resonant pulsed 
excitation enhance the photonic inactivation of the tested Gram-negative and Gram-
positive bacteria, mycoplasma, phages and enveloped viruses but do not induce a 
significant loss in mammalian cell viability. The maximum inactivation remains lower for 
E. coli and B. subtilis than for mycoplasma, which suggests that larger bacteria with cell 




The central physical innovation in this study is the adaptation of the well-established 
principle of plasmonic enhancement of Near-Infrared (NIR) ultrashort pulses to the 
photonic inactivation of a broad range of pathogen species. We validated the efficacy of 
the plasmonic enhancement scheme for phages, mycoplasma and Gram-negative and 
Gram-positive bacteria. The plasmonic enhancement facilitated an effective photonic 
 
Figure 3-6 Percentage of viable Chinese hamster ovary (CHO) cells without laser irradiation 
(control), cells after incubation with a nanorod (NR) solution (no laser) for 30 min, and cells treated 
with a NR solution that were exposed to pulsed (100fs) 800 nm laser with 3 W power for 10s and 




inactivation of a broad range of biologically diverse pathogens at an operational 
wavelength of 800 nm. We achieved LRV of > 7 for φX174 and up to 6.7 for A. laidlawii, 
3.4 for B. subtilis and 4.7 for E. coli using pulsed radiation in the presence of resonant NPs. 
The plasmonic enhancement of photonic inactivation also allowed for a faster treatment of 
the samples. In the case of the bacteria, for instance, we decreased the exposure time from 
hours to a few tens of minutes and increased the treated volume by more than 1 order of 
magnitude compared to conventional pulsed laser viral inactivation methods. 48 For φX174 
we achieved inactivation within minutes compared to hours for conventional photonic 
inactivation reported in previous studies. 39 For membrane-wrapped viruses plasmon-
enhanced photonic inactivation was even accomplished within tens of seconds. 86 We also 
successfully demonstrated in the case of φX174 that the plasmonic enhancement of 
photonic inactivation is compatible with a flow-through mode, which provides new 
opportunities for improving the throughput and scalability of photonic inactivation 
schemes that are effective against a broad range of pathogens. 
Plasmonic NPs resonant in the NIR made it possible to operate in a wavelength range 
with minimal collateral damage to co-incubated antibodies, which proves the intrinsic 
value of the technique to selectively inactivate pathogens while retaining the activity of 
biologics. Biologics are among the fastest growing class of therapeutic agents in Public 
Health. 156-157 As for all pharmaceuticals derived from cultured cells, microbial 
contamination is an integral risks of biologics production. 158-159 Despite different upstream 
clearance steps for starting materials, filtration is currently the only technology that can 
retain potential microbial contaminations without harming the product in monoclonal 
 
62 
antibody fabrication. Removal especially of virus and mycoplasma pathogens through 
passive filtration faces a series of scientific and technical challenges and remains a crucial 
step in the manufacture of biologics. As plasmon-enhanced photonic inactivation has been 
demonstrated to yield LRV > 4 for non-enveloped viruses φX174 (this study) as well as 
enveloped MLV, 86 this novel photonic technology provides an alternative strategy to 
overcome these longstanding challenges associated with small viruses and mycoplasma 
and, at the same time, retains efficacy against larger bacteria. We envision that the 
technology can eventually also be translated to patient-related applications, for instance, to 
fight antibiotic-resistant topical infections and sterilize dermal and other acute wounds, etc. 
that are accessible for NR treatment. The urgent need for alternative strategies to combat 
microbial infections in a time of failing antibiotics provides this research additional 
significance. 160 This work underlines the potential of plasmonic NPs to enable new 
“physical” antimicrobial strategies that could in the future complement existing molecular 
strategies. 
 
Materials and Methods 
Set-up of Laser Inactivation. We investigate the photonic inactivation of the different 
samples via two different laser wavelengths, at multiple treatment times for two different 
modes; batch mode and flow-through mode. The excitation source employed in this work 
were fs lasers. We either used a Ti:sapphire based laser pulses (800 nm, 1 kHz) with a 
regenerative amplifier system (Libra-F-1k-HE-110, Coherent, CA) with 3 W power that 
generated 100 fs pulses. Alternatively, we used a Legend Elite Duo (Coherent Inc.) Ti-
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sapphire regenerative amplifier, which produces a continuous train of 35 fs pulses at a 
repetition rate of 1 kHz centered at 800 nm with energies up to 7 mJ per pulse, with the 
tightest laser spot size of approximately 0.9 cm2. A dichroic beam splitter directs half of 
the laser beam to an optical parametric amplifier, or to a frequency doubling crystal. In this 
arrangement, up to 3 W of average power are available at the fundamental and 2.5 W of 
power in frequency doubled generated light. In batch mode, typically 1.5 mL of pathogen 
solution was transferred to quartz cuvette and a magnetic stirrer was used to facilitate the 
interaction of laser beam with pathogens. Virus and bacteria samples were assayed using a 
plaque-forming assay and standard plate count agar method, respectively. An alternative 
arrangement to test the prospects for larger scale processing was investigated in a flow 
chamber connected to a syringe pump (flow-through mode). Briefly, a flow cell of 2 mm 
depth made of Quartz was connected to a reservoir and a syringe pump was used to slowly 
drive the samples past the incident laser beam, with typical infusion flow rates of 2 mL/h 
and withdraw fusion rate of 100 mL/h. To check against non-uniform exposure in these 
unstirred samples undergoing laminar flow in the 2 mm depth, the syringe pump was 
operated in both infuse and withdraw mode, up to a total of three times. Control samples 
consist of a sample flowed through the cell without any exposure and another sample which 
held in refrigerator. Figure AII-1 of the Appendix II, shows the corresponding LRV 
obtained for φX174 with two different flow rates. Also, to test the potential toxicities of 
gold NPs, similar unexposed control experiments were performed with A. laidlawii, B. 
subtilis, E. coli in the presence and absence of NPs in batch mode (Figure AII-1).  In this 
study, virus and cell experiments were performed in triplicate and bacteria experiments we 
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performed at least in duplicate. 
 
NR and BP Synthesis. Tetrachloroauric acid (HAuCl4, ≥ 99%), 
hexadecyltrimethylammonium chloride (CTAC, 25 wt% in water), 
hexadecyltrimethylammonium bromide (CTAB, ≥ 99%), citric acid (≥ 99.5%), sodium 
borohydride (NaBH4), silver nitrate (AgNO3, ≥ 99%), hydrochloric acid (HCl, 37%), L-
ascorbic acid (AA, ≥ 99%) were purchased from Sigma-Aldrich. All chemicals were used 
without further purification. Milli-Q water (resistivity 18.2 MΩ·cm at 25 °C) was used in 
all experiments. Gold bipyramids were synthesized and purified as described in the 
literature. 161-162 Gold NRs were synthesized using the seed-mediated growth technique 
described by Vigderman et al. 163 To obtain PEGylated NRs, 2.5 µL of 10 mM PEG2 (HS–
CH2CH2–(C2H4O)77–N3) were added together with 2.5 µL of 10 mM HS-(CH2)11-
(CH2CH2O)6OCH2-COOH to 1mL of gold NRs in the presence of 3% v/v of Tween 20. 
The samples were incubated overnight and washed by centrifugation and subsequent 
resuspension. Alkyne-functionalized annexinV was cross-linked to the azide 
functionalized NRs in the presence of 500 µM ascorbic acid and 100 µM CuSO4 via CuI 
catalyzed click-reaction. 125 The NRs were cleaned again through repeated centrifugation 
and resuspension in DDI water or buffer. The PEGylated bipyramids were obtained by 
following a similar procedure. A schematic representation of the synthesis of NPs is given 




φX174 Sample Preparation. φX174 samples (Promega TiterMax φX174 Bacteriophage) 
with 2 × 1012 plaque forming unit per mL (pfu/mL) concentration in 0.05 M sodium 
tetraborate were stored at -80°C. Then the φX174 virus for our experiments were prepared 
by serial dilution of stock sample in Sorenson buffer (pH 7.3) to the final concentration of 
1×106 pfu/mL, and 1×109 pfu/mL. For samples containing plasmonic NPs, φX174 with 
initial titer of 109 pfu/mL was combined with around 100-fold excess gold NRs to form a 
sample volume of 1.5 mL  
 
φX174 Plaque Assay. φX174 samples were diluted with Sorenson buffer, and assayed by 
adding 0.1 mL of diluted sample and 0.1 mL of host cell suspension to a test tube. The test 
tube contains 3 mL of molten (46-48 °C) φX174 overlay agar consist of 5 g of NaCl per 
liter of reagent water, 8.5 g of agar and 10 g of tryptone peptone. Then the solution of 
bacteriophage and host cell was transferred to the φX174 bottom plate agar containing 10 
g of tryptone peptone, 10 g of agar, and 1 mL of 1 M CaCl2 per liter of reagent grade water, 
 
Figure 3-7 Schematic illustration of the synthesis of gold nanorod and bipyramid. 
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2.5 g of NaCl, 2.5 g of KCl, and then incubated overnight at 37 °C. Then the plaque 
counting result is being reported as pfu/mL. Sorenson phosphate buffer, φX174 overlay 
and bottom plate agar were purchased from Northeast Laboratory Services (Winslow, ME). 
 
B. subtilis Preparation. Glycerol stocks (glycerol: Fisher Scientific BP229-1) of B. 
subtilis subspecies subtilis strain 168 (NCBI accession: NP_000964) were inoculated in 
liquid 5mL LB cultures (Fisher Scientific BP1426-2) and grown overnight (37C, shaking 
250rpm, 16 hours). The following day, overnight culture was diluted in 45mL of LB broth 
and grown for another hour (37°C, 250rpm). Bacterial culture with initial titers of ~ 109 
CFU/mL was then transferred to a 50mL centrifuge tubes (Denville Scientific C1060-P) 
and sent for laser exposure. For samples containing NPs, PEGylated NRs were added to 
the bacterial culture tube to final volume of 1.5 ml which is illuminated for 20 min with 
800 nm radiation. The NR to bacteria ratio was around 100:1. 
 
B. subtilis Colony Counting. Following laser exposure, samples were serially diluted by 
taking 100 µL of the sample and ejecting it in 900 µL LB. This was then briefly vortexed 
to mix before taking 100 µL of the diluted sample and adding it to 900 µL of fresh LB. 
This was done over seven orders of magnitude. 100 µL of diluted samples were then plated 
on LB agar plates (Fisher Scientific BP1425) and grown for 16 hours at 37°C. Viable 
colonies were then counted and the dilution factor was used to calculate colony forming 




A. laidlawii Culture Preparation and Assay. Oleic and palmitic acids were prepared 
separately in 100% ethanol to achieve a concentration of 10 mg/mL each.  Each fatty acid 
was filter sterilized and stored separately. Glucose hydrolysate broth (GHB) was prepared 
with 4% w/v polypeptone, 0.5% w/v Trizma Base (2-Amino-2-(hydroxymethyl)-1,3-
propanediol), 0.78% glucose, and 0.4% bovine serum albumin (BSA) in Milli-Q water.  
Oleic acid and palmitic acid were aseptically added to deliver a final concentration of 
0.002% w/v each.  Glucose Mycoplasma Agar (GMA), Part 1 contained: 2% w/v 
Mycoplasma Broth Base, 0.5% w/v Trizma Base, 0.78% w/v glucose and ASTM Type 1 
water. This preparation was sterilized in a validated slow exhaust cycle at a minimum of 
121.1 °C.  Sterile GMA Part 2 contained: 0.78% w/v glucose, 0.4% w/v BSA and ASTM 
Type 1 water and filter sterilized. All components were tempered and aseptically added.  
Oleic acid and palmitic acid were aseptically added to Sterile GMA Part 2 to deliver a final 
concentration of 0.002% w/v each. The agar base was tempered and aseptically added to 
the GMA Part 1 and the Sterile GMA Part 2 to arrive at a dispensing temperature of 43 to 
45°C.  
A frozen stock vial of A. laidlawii ATCC 23206™ was rapidly thawed and transferred 
to GHB broth in order to achieve a final concentration of 4% (v/v) inoculum to broth.  
Cultures were incubated at 37ºC (± 2ºC), with 6% (± 1%) CO2 for 22 (± 2) hours. A. 
laidlawii from a 22 (± 2) hour culture in GHB was diluted into Mycoplasma Phosphate 
Buffer to deliver a minimum final target concentration of 1 x 108 -1 x 109 CFU/mL. 
PEGylated NRs was added to the mycoplasma suspension followed by 5 hr incubation at 
4 °C. Then, 1.5 mL of samples were irradiated with 800nm laser for 30 min. The NR to 
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bacteria ratio was around 100:1. Samples of the A. laidlawii culture and the A. laidlawii 
challenge suspension were serially diluted in mycoplasma buffer and enumerated using the 
pour-plate method with GMA agar.  Plates were incubated at 37ºC (± 2ºC), with 6% (± 
1%) CO2 for 4-7 days. Post-incubation the pour-plates were enumerated.  
 
E. coli Samples Preparation. Glycerol stocks of E. coli strain K-12 substrain MG1655 
(NCBI accession: U00096) were inoculated in 5mL of liquid LB broth (Fisher Scientific 
BP1426-2) and grown overnight (37C, shaking 250rpm, 16 hours). The following day, 
overnight culture was expanded by adding the 5mL of overnight culture to 45mL of fresh 
LB broth and incubated (1 hour, 37C, shaking 250rpm). Expanded bacterial culture with 
initial titers of ~ 109 CFU/mL was then transferred to a 50mL centrifuge tube (Denville 
Scientific C1060-P). For E. coli samples containing gold nanorods, the nanorods to bacteria 
ratio was around 100:1 to form a sample volume of 1 mL and laser exposed samples were 
illuminated for 30 min with 800 nm radiation. 
 
E. coli Viability Assay. Following laser exposure, samples were serially diluted by taking 
100 µL of laser-exposed bacterial culture and adding it to 900 µL of fresh LB broth. This 
was then briefly (2-4s) vortexed to mix and then serially diluted by taking 100 µL of the 
diluted culture and adding it to another 900 µL of fresh LB. This was done over seven 
orders of magnitude. 100 µL of the diluted samples were then plated on LB agar plates 
(Fisher Scientific BP1425) and grown overnight at 37C. The following day, colonies were 
counted and the order of magnitude of the dilution was used to calculate colony forming 
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units of the original, laser-exposed sample. 
 
Chinese Hamster Ovary (CHO) cell Sample Preparation. The CHO cells used in this 
study were from Thermo Fisher Scientific (FreeStyle™ CHO-S Cells). The cells were 
grown in FreeStyle™ CHO Expression Medium. This medium, which is animal origin-free 
and protein free, was supplemented with 8mM glutamine. The medium does contain 
Pluronic F-68, however the actual concentration used was propriety information (by Thermo 
Fisher Scientific). The cells were grown in 125 mL shaker flasks, spun at 125 rpm on a 
shaker table, in a humidity controlled incubator, kept at 37 °C and 8% CO2 concentration. 
The cells concentrations was ~2-107 cells/mL. Cell were combined with more than 1000-
fold excess gold NRs to form a sample volume of 1.5 mL.   
  
Chinese Hamster Ovary (CHO) viability Assay. CHO cell viability was measured using 
a Thermo Fisher Scientific Countess II Automated Cell Counter utilizing a Trypan Blue 
exclusion dye. An experimental sample of CHO cells, with or without NRs, was presented 
in a microcentrifuge tube for measurement. The viability was then obtained accordingly; 
200 microliters of the sample was added to 200 microliters of 0.4 % Trypan Blue in a 1.5 
mL sterile centrifuge tube. The mixture was then vortexed and 10 microliters each aliquoted 
into two wells of the disposable Countess II slides. After a 30 second settling period the 
slide was inserted into the cell counter and the cell concentration and the viability was 
obtained in duplicate (from both wells of the slide). The Countess II optically examines the 
image, and determines the dead cells by the uptake of the trypan blue dye. 
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Log Reduction Value Calculation. The results for the pathogen inactivation assays are 
reported as the LRV, which is a measure of the ability of the treatment processes to 
inactivate pathogenic microorganisms.  LRVs are determined by taking the logarithm of 
the ratio of pathogen concentration in the untreated and laser exposed sample (shown in 
Equ. 3-1).  
  
 
 where CU and CT are the concentration of the untreated and treated samples, respectively. 
 
Statistical Analysis. The ANOVA test is performed in MATLAB to analyze the variability 
in the LRV data. The notation NS is used to emphasis on non-significant differences 
between samples while the significance level of differences of P < 0.05 are marked with 

















We report on detection of virus inactivation using femtosecond laser radiation by 
measuring the conductance of a solid state nanopore designed for detecting single particles. 
Conventional methods of assaying for viral inactivation based on plaque forming assays 
require 24–48 h for bacterial growth. Nanopore conductance measurements provide 
information on morphological changes at a single virion level. We show that analysis of a 
time series of nanopore conductance can quantify the detection of inactivation, requiring 
only a few minutes from collection to analysis. Morphological changes were verified by 
dynamic light scattering (DLS).  Statistical analysis maximizing the information entropy 
provides a measure of the log-reduction value. This work provides a rapid method for 
assaying viral inactivation with femtosecond lasers using solid-state nanopores. 
 
Introduction  
Existing and emerging viruses are a major threat to human and veterinary public health. 
The need for safe and reliable inactivation or removal of viruses is universal in antiviral 
therapies, pharmaceuticals, and viral vaccine development. Conventional pharmaceutical 
pathogen inactivation methods are quite effective, but they involve substantial collateral 
damage and have undesirable side effects. 164-166 Chemical-free viral inactivation methods 
such as ultraviolet and gamma-irradiation have been used to minimize some of the side-
effects. Nevertheless, these methods adversely affect thermolabile compounds and 
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denature biomolecules of interest in the medium containing the virus. Ultrashort pulsed 
lasers (UPL) provide new opportunities for chemical-free pathogen disinfection in 
solution. Photonic methods have the potential to provide an attractive alternative to existing 
biocides and ionizing radiation techniques.41, 86, 167-169 Photonic inactivation has been 
successfully achieved with focused femtosecond (fs) laser pulses for exposure times of ≥ 
1h on sample volumes typically of ≤2 ml.41, 167-171 Although the ultrafast laser inactivation 
method for viral inactivation is fairly well established, a systematic understanding of the 
inactivation mechanism is currently lacking. There is a need for rapid methods for assaying 
viral inactivation in order to carry out multi-dimensional studies of the ultrafast laser 
parameters such as intensity, pulse duration and center wavelength that can contribute to 
the design and optimization of inactivation protocols. 
Viral inactivation is a complicated process and its outcome highly depends on the specific 
treatment method. A wide range of biological assays could detect and quantify intact 
viruses in an ensemble manner which is extremely laborious, time-consuming, with low-
sensitivity.172 A different approach is to explore viruses at the single virion level. Different 
optical methods have been developed to characterize single virus particles;173-175 but still 
there is a need for a technique that is fast, sensitive and uses small sample volumes. 
Although imaging techniques, such as AFM and TEM, are capable of characterizing 
viruses with high sensitivity, results will be inevitably affected by the tedious and costly 
sample preparation steps. Nanometer-sized pores in a membrane offer the capability of 
electrically detecting molecules in a label-free manner at single-molecule level in a volume 
as small as a few microliters and detection times as short as a few seconds. Passage of 
 
73 
molecules and particles through a nanopore causes transient disruption in the ion current 
through it, from which the size, concentration, and distribution of analytes can be 
deduced.176-177 The electrical signal characteristics in a given analyte sample strongly 
depend on the analyte passing through the pore, the pore geometry, and the experimental 
conditions such as pH, ionic strength, applied voltage, temperature, etc.  This single-
particle electrical sensor has been used for quantifying the conformational properties of 
proteins,70-76 understanding DNA transport67-69 and detecting small molecules,77-78 among 
many other applications. Previous studies have reported the ability of nanopore sensors to 
detect spherical and icosahedral viruses,79  virus capsids,80 the masses and zeta potentials 
of viruses,81-82 and to explore the translocation of a stiff, rod-shaped virus.83  
This ability of nanopores to detect the translocation of nanometer size particles motivated 
us to study the effect of an optical viral therapy on the single virus level, crucial for the 
preparation of very safe biotherapeutics. In this study, high incident fs laser intensities of 
>100 GW/cm2, which are more than 105 times greater than used in previous studies, have 
been used to inactivate viruses, leading to 4-log reduction in viral activity in 1 min 
irradiation of ~ 2 ml sample volume. This result shows nearly more than two orders of 
magnitude improvement in treatment time compared to conventional pulsed laser viral 
inactivation methods.178 Furthermore, we demonstrate the capability of the nanopore 
technique to precisely characterize individual viruses, explore how vital viral function is 
affected by treatment, and quantify the effectiveness of this label-free viral inactivation 
technique is. In light of these points, we investigate the effects of fs laser on inactivated 
φX174 bacteriophage, which has the first sequenced DNA-based phage genome widely 
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used standard for viral clearance, as well as a surrogate for enteric human viruses. 179 
Changes in the physical properties of treated virus samples are monitored by electrically 
counting viruses in a small sample volume. A statistics-based method, has been developed 
to monitor the reduction value of viruses using sequential nanopore measurements, and 
compared with a plaque forming assay. Moreover, the effect of inactivation on viruses in 
an ensemble manner and at the single-virus level resulting from dynamic light scattering 
(DLS) measurements and nanopores, respectively, are compared. 
 
Results and Discussion 
Obtaining extremely high levels of viral clearance is a substantial step in the purification 
of protein-based therapeutics. The presence of even a single virus in the final drug product 
could be harmful to the consumer’s health. To prevent this, implementation of an effective 
viral inactivation strategy is crucial.  USP viral inactivation with greater than 4-log 
reduction in viral infectivity would enable a new chemical free pathogen clearance 
technology. 178, 180-181 The first objective of this study is to extend the work done on USP 
inactivation of viruses, using a regeneratively amplified laser system. We expedite the 
reported USP photonic inactivation (>1 hr) 178 to 1 min. In this study, 35 femtosecond 
pulsed laser irradiation working at ~ 400 nm is used to irradiate 2 ml of φX174 
bacteriophage for different irradiation times (Figure 4-1a). Inactivation of viruses is 
measured by viral infectivity assay. Original sample concentrations were calculated by 
multiplying the plate count by the dilution factor, reported as pfu mL-1. 182 
The final results for the viral inactivation experiments is reported as the log reduction 
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value (LRV) which provides a direct measure of viral inactivation. The LRV was 




here is the concentration of the untreated sample and  the concentration of the treated 
samples exposed to the laser irradiation as described. Control samples consist of a sample 
with no laser exposure which was kept refrigerated during the experiment and another 
sample which experienced the same pipetting and stirring condition as treated sample but 
without the laser exposure. These control samples never differed significantly and were 












Figure 4-1 (a) Schematic of experimental setup for photonic viral inactivation. The following 
abbreviation are used: fs: femtosecond, QC: quartz cuvette, BBO: Beta barium borate. (b) Log 
reduction value (LRV) measured for φX174 virus with 106 pfu ml–1 (patterned) and six-orders of 






more than 104 reduction values of φX174 with 106 pfu ml-1 concentration is achieved by 
irradiating 2 ml of virus suspension with 2.5 W (average power) ~ 400 nm femtosecond 
laser pulses for different treatment times ranging from 1 to 15 min. The relatively large 
laser beam diameter of the regeneratively amplified laser beam results in fast viral 
treatment which can overcome the need for long irradiation times, and remove constraints 
on the corresponding practical implementation.  
 
Label-free Detection of Single Viruses using Nanopore  
The next goal is to precisely monitor changes occurred to the treated viruses on the single 
virus level. A 20 µl aliquot of φX174 with ~1012 pfu ml-1 is treated for 15 min exposure 
with the same laser setup. For this low volume of sample, we used a micro quartz cuvette 
with no stirring. Again, the strong reduction in viral infectivity (LRV>3) was achieved for 
six-orders of magnitude increased virus concentration (Figure.  4-1b). 
As shown in Figure 4-2, the φX174 viruses are being voltage-driven through a ~38 nm 
pores made of SiN. A TEM image of the pore is shown as an inset. The pore size is 
intentionally chosen close to the virus size to slow down the translocations and allow for 
accurate measurement of the events. Viruses are electro-osmotically driven through the 
nanopores upon application of a negative bias to the trans-chamber. The application of 
voltage results in a steady-state countercurrent of K+ and Cl- ions across the pore, which 
produces a stable baseline open pore current, 𝐼(.  When 0.5 µL of virus sample is added to 
50 µL of buffer in the cis chamber, passage of individual viruses through the pore reduces 
the ionic current, which results in a spike in the measured current. This volume was 
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sufficient to generate > 2×103 events in 10 s for good statistics in the untreated sample. The 
spike contains information about single virions, which can be extracted using statistical 
analysis methods. The current is measured by a Chimera VC100 amplifier which streams 
1 MHz bandwidth data to a computer at a sampling rate of 4.17 MHz, followed by 
application of a 100 kHz low-pass filter in software to reduce the high frequency noise 
dominated by the chip capacitance. The choice of the 100 kHz low-pass filter reflects a 
compromise that enables detection of events with a sufficient sampling time-resolution of 
one order of magnitude smaller than the virus translocation times, and the loss of higher 
frequency information.  
Figure 4-3a shows continuous current traces obtained when untreated φX174 viruses 
were added to the cis chamber at 40 mV applied voltage. Each spike corresponds to 
 
Figure 4-2 Schematic of the nanopore setup for virus detection. Pores are fabricated in 
freestanding SiN membranes and an external bias is applied across the membrane to drive φX174 
viruses, potassium ions (yellow dots) and chloride (red dots) ions through the pore. Inset: TEM 






transport of a single virus through the ~38 nm pore. The electric signal represents two 
predominant current levels, the higher one corresponds to the open pore current when 
viruses do not translocate through the pore, 𝐼(, and the lower corresponds to the virus-
occupied level. Based on the measured open pore current which is 1.13 nA, the pore 
conductance was calculated as G = 28.2 nS. The inset shows a magnified view of a 
randomly selected event corresponding to individual intact φX174. The translocation 
current, , which is the difference between the baseline current and the pulse minimum, 
depends on pore geometry and virus size. Based on the known nanopore diameter of 38 
nm, the nanopore length was estimated from the open pore conductance to be  ℎ;<< =
35	𝑛𝑚. This value, thinner than the overall initial 50 nm membrane thickness, h, was still 
thicker than the expected thickness of ℎ;<< = ℎ/3 previously found for the very narrow 
pores. 183 As shown in Figure 4-3d, the mean fractional current blockade for untreated 
φX174 virus is measured to be 27%. This number is consistent with the 29% blockade 
predicted by the following theoretical equation, derived in Appendix III, for a 30 nm 




In which  is the open pore resistance and   is the nanopore resistance 























Here 𝑑 is the virus diameter, is the pore diameter, and 𝜎 is the salt conductivity which 
for the 100 mM KCl buffer was measured as 16.7 mS cm-1 using the conductivity meter.   
 The agreement between theoretical and experimental translocation ratio verifies that the 
untreated viruses maintain their shape integrity during transport through the pore. 
Additionally, a 1D drift-diffusion model can be used to describe the dwell time distribution 
of virus translocation through the nanopores. Fitting the probability density function of 
dwell time distribution ( ) with the following equation yields two important parameters: 





Application of this equation, which is based on the assumption of barrier-free transport, 184 
for the untreated viruses (Figure 4-3e) yields  and . 
To gain insight into the virus transport kinetics through this nanopore, we compare the in-
pore diffusion coefficient of viruses with a bulk diffusion coefficient, using 
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absolute temperature,  the viscosity of the solution, and d the hydrodynamic diameter of 
the virion. Using DLS we measured average diameters of ~30 nm at 23°C, and accordingly, 
  was calculated as . The result shows small reduction in  which can be a 
consequence of virus-pore hydrodynamic interaction, as previously observed with protein 
transport through smaller pores. 185 Upon successful detection of untreated viruses using 
nanopores, we probed the effect of laser treatment on the virus sample. A time trace for 
translocation of laser treated φX174 with LRV>3 (Figure 4-1b) is shown in Figure 4-3b. 
There is a drastic change in the time trace of laser irradiated viruses as compared to 
untreated samples which will be explored in more detail. The averaged baseline 
conductance remained constant to within 1% over the data collection timescale, indicating 
that the nanopores did not expand and were not blocked by debris or other particles. 
h
bulkD




Probing Viral Inactivation using Nanopore Measurements  
To explore the effect of laser treatment, the scatter plot of fractional current blockade 
versus dwell-time of treated and untreated viruses at 40 mV voltage is shown in Figure 4-
3c. Two clear groupings of events are visibly noted, corresponding to the treated and 
untreated viruses which can be visually distinguished by drawing a line as shown in Figure  
4-3c. A histogram of fractional current blockades and dwell-time distributions for both 
treated and untreated samples at 40 mV along with generalized extreme value distribution 
 
Figure 4-3 . Comparison of pre-treatment and post-treatment of φX174 virus with a pulsed (35 fs) 
800&400 nm laser with an average power of 2.5 W for15 min. a,b) Continuous ion current traces 
collected using a 40 mV applied voltage low-pass filtered to 100 kHz, Inset: Zoomed=in portion of 
selected representative events. c) Scatter plot of fractional current blockade percentage, FI (%) at 40 
mV (0.1 M KCl, 20°C) vs dwell time, td.  d) Histograms of fractional current blockade at 40 mV 
showing decrease in FI (%) after laser treatment. e) Histograms of dwell time at 40 mV voltage 




fits to the distributions are shown in Figure 4-3 d-e respectively. The untreated sample is 
centered at FI = 25.04+/-3.1 % with log10(td) = 2.05+/-0.36 (td measured in µs) and the 
treated sample is centered at FI = 10.4+/-2.7 % with log10(td) =1.3+/-0.12. These two sets 
of independent parameters (FI and td) clearly show the effect of laser treatment on viruses. 
The FI is related to the size of the particle and hence a strong decrease in the fractional 
blockade yields the first important information on the effect of fs laser treatment, i.e., the 
global appearance of the non-enveloped φX174 virus does not remains intact after 
treatment which is in agreement with previously established data. 41 Measurements of the 
fractional blockade with slightly larger diameter nanopores (dp ~ 39-40 nm) gave results 
similar to those reported in Figure 4-3 whereas a smaller diameter nanopore produced 
events with larger dwell times.  A systematic study of the pore size dependence on treated 
and untreated samples was not attempted, given the limited scope of the present study. 
  Using the capability of our label-free resistive pulse technique, one can monitor the 
inactivation of viruses by looking for the presence of intact viruses in the solution with 
high sensitivity. One simple model is to consider an ellipse in the scatter plot of untreated 
events centered at the mean value of fractional current in y direction and the mean of 
log10(td) in x direction. The semi-minor and semi-major axis radius of this ellipse is equal 
to three times the standard deviation of the FI and log10(td) of untreated events, respectively. 
(Figure 4-4a). The standard deviations are obtained based on the Gaussian fits of the 
corresponding data. Counting the number of the treated (red) data points in the black ellipse 
gives us a rough estimate of the number of intact viruses in the treated sample, n. The 
number of points in untreated and treated scatter plot is 2,723 and 2,564, respectively. The 
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ratio of n to the total number of red data points of the treated sample, , gives us an 
estimation of the survival fraction (r)  
 
 (4-4) 
where fI and fT are the capture probabilities of intact and treated virus. Assuming these 
probabilities to be equal in this case, the survival fraction is approximately 0.02. This 
quantity can provide a simple method for rapidly estimating the efficiency of the 
inactivation technique. 
 
A more precise way to estimate r using nanopore data is to determine an upper bound for 
the number of survived viruses after treatment. To find the upper bound we developed a 
statistical formula that employs a probability distribution function derived from Figure 4-
3d. The first step is to estimate the probability of finding a translocation event of the treated 
sample with a distinguishing feature  inside the untreated sample region with . In a 
simplest case  and  can be any feature that can separates the two populations; in our 
case it can be fractional current blockade, dwell time or any other combination of these 
two. For example, if we consider this one-dimensional scaler as the fractional current 
blockade, in our case there is a big separation between the mean of untreated events, , 
and treated ones, , so that . Some of the viruses in the treated sample could be 
intact. We can quantify this possibility by considering the probability  that an 
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function for the untreated sample: . Thus, for the treated data points that 
are far away from the untreated events, the result would be zero while for the ones which 
has overlap, the result is more than zero. By assuming all untreated viruses are intact, we 
can consider a threshold, ε, on the probability PI, and using a heaviside step function, θ, we  
decide if an event can be counted as an intact virus (if ) or not (if ). By 
applying this threshold on all events, we can define a function ρε as equation 5 which is a 
sum on all treated data points normalized by the number of treated events, N.  
( ) ( )I T U TP x CDF x=
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Figure 4-4 a) Scatter plot of fractional blockade of untreated (green) and treated (red) viruses versus 
event duration, under a driving voltage of 40 mV b) upper bound determination of the survival 
fraction, inset shows the zoom in portion of the graph. The minimum occurs at ε= 0.2294 and rmax 











So after treatment, there is ρε×N number of events in the treated sample which have the 




where n in the first part is the actual number of intact viruses in the treated sample, and 
is the probability of counting a broken virus as an intact one in the treated sample. In this 
calculation, since , the r which is n/N, will be bounded by . By minimizing 
the   over the ε one can determine the upper bound for survival fraction. However, 
there is another point to explore. This value of r has a large error bar due to the shot noise, 
so that the error in estimating n  is proportional to the . In practice for large enough 
epsilon there will be no data points satisfying the condition of and the estimated 
value of ρε would be zero. Thus as a practical approach, we consider a cutoff and vary 
epsilon from 0 to the maximal value at which , where 5 is an arbitrary threshold 
that controls how accurate this method is. As shown in Figure 4-4b and Figure AIII-2,  in 
our case, rmax can be estimated as 2.5´10-3 which is similar to the inverse of the reduction 
value ~103 reported using infectivity assays (Figure 4-1b). So these data demonstrate that 












( )(1 )N n N n qe er e´ = ´ - + - ´
qe














the nanopore method; while in contrast to the conventional infectivity assays, the nanopore 
technique is capable of probing small damages to the viruses in linear base with high 
precision. 
 
Possible Morphological change implied by fs laser on φX174 virus 
Generally the electrophoretic driving force and electroosmotic flow are the main effects 
that govern a particle’s motion in a nanopore 186. The first one originates from the force 
exerted to the charged nanoparticle in an electric field and the second one is due to the 
viscous drag by the fluid flowing through the charged nanopore in response to the applied 
voltage. Combining the equations for electrophoretic and electroosmotic transport yields 




where  is zeta potential, η and ε are the viscosity and permittivity of the electrolyte.  For 
our negatively charged viruses attempting to translocate through the nanopore with 
negative surface charge, these two forces oppose each other and the relative magnitudes of 
the forces determines the direction and duration of translocations 188.  
In our study, electroosmotic flow is a dominant factor, and therefore, the difference in 
membrane and virus surface charge plays a dominant role on capture and transport. We 
were not able to observe a statistically significant difference between the zeta potential 




associated with treated and untreated virus samples. As shown in Figure 4-3e, the dwell 
time of most of the events in the treated sample are <90 µs, while untreated viruses have 
much longer dwell times. In addition, upon treatment, the dwell time distribution narrows 
substantially and the fractional current blockades are reduced, which can be attributed to a 
morphological change in the virus sample.  
To further examine the impact of fs laser pulses on virus conformation, we employed 
DLS to characterize changes in the radius of φX174 viruses and its DNA caused by laser 
treatment. The DLS measured the average diameter of the untreated viruses 30.9±2.3 nm 
(Figure 4-5a), which is in agreement with the known φX174 particle size.189 The DLS 
results demonstrate two useful pieces of information: first it shows that the laser-treated 
sample no longer possesses a monomodal size distribution and a second peak is observed 
at 458±56 nm which will be discussed shortly. Another important piece of information can 
be obtained from the intersection of the correlation curve on the y-axis of the correlogram. 
This y-intercept is related to the signal-to-noise ratio of the measured sample. As shown in 
Figure 4-5b the correlation coefficient for the treated φX174 viruses has a lower y-intercept 
of 0.4 compared to the untreated one which is ~0.85. The lower y-intercept in the treated 
sample can be attributed to the concentration variations in this sample and presence of 458 
nm particles. This concentration variation can also be explored by nanopore measurements. 
In case of the nanopore measurements, the waiting time between two successive events (δt) 
is inversely proportional to the concentration of the detectable particles. An exponential fit 
to the waiting time data (Figure 4-5c), indicates that capture rate of the viruses has 
decreased by more than one order of magnitude after laser treatment at the same voltage 
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bias (40 mV). Capture rates for untreated and treated samples were 52±0.87 s-1 and 
3.49±0.13 s-1 respectively.  
Particles of the second mode in the DLS data of φX174 viruses have a hydrodynamic 
radius that is too large to be detected with our 38 nm nanopore. To investigate the second 
peak, we performed DLS measurement of φX174 virion DNA, the single-stranded viral 
DNA isolated from purified phage by phenol extraction (New England Biolabs). This 
measurement indicates if the second peak is a signature of free DNA ejected from virus 
under photonic exposure. The DLS measured average diameter of the untreated phenol-
extracted DNA was 113.5±30 nm. A part of this variation may be attributed to ~ 15% of 
the phenol-extracted DNA molecules not being in circular form. The radius of gyration, Rg 
and hydrodynamic radius, Rh. of free φX174 DNA polymer can be estimated as  
 
 
Figure 4-5 a) DLS size distribution obtained from b) Quasi-elastic light scattering intensity 
autocorrelation function or correlogram of φX174 virus before (untreated) and after irradiation (treated) 
with IR& blue 35 fs laser pulses for 30 min (average laser power 2.5 W) c) inter-event waiting time 
obtained from nanopore measurement of the data in figure 4-3 at 40 mV applied bias, fitted by an 
exponential function. d) Size distribution e) Correlogram of φX174 viral DNA. Laser irradiation 











from the known persistence length P and the contour length Lc. 190-192 For φX174 DNA 
with 5386 nucleotides and the persistence length ~4.6 nm for DNA, 193  the Rg and Rh can 
be estimated as 72 nm and 45.6 nm, respectively. 184, 194 So the corresponding 
hydrodynamic diameter is approximately  91 nm which is consistent with the peak in DLS 
measurement of untreated DNA.   Interestingly, DLS data of laser exposed DNA (Figure 
4-5d), still contains this peak which argues against complete agglomeration of single-
stranded DNA due to laser exposure. Also, as the correlogram of the DNA (Figure 4-5e) 
shows there is little difference in the time autocorrelation function between exposed and 
unexposed DNA samples. Our observations indicate that the 458 nm peak observed in 
laser-treated φX174 viruses sample is thus not from the presence of free single-stranded 
DNA.  
Based on our data after laser treatment there are three possible morphology changes that 
can happen to φX174 viruses: (i) fragmentation to small pieces, (ii) perforation of viruses 
that leads to DNA expulsion with a small associated change in the virus shell, and (iii) 
agglomeration of viral particles (Figure 4-6). Nanopore data can be used to evaluate each 
of the possibilities. The fact that the fractional current blockade decreases after treatment, 
suggests that the particle diameter gets smaller upon laser exposure. Also if we neglect 
possible changes in the zeta potential of the viruses, the smaller viruses will translocate 
faster consistent with the observation of a shorter dwell times in the treated sample. 









smaller than the original viruses, and support the hypothesis of virus perforation. At the 
same time, the nanopore capture rate suggests that viruses for the most part have been 
fragmented to small pieces not detectable by the nanopore conductance.   
Neither DLS nor nanopore data do not suggest extensive virus agglomeration. Since the 
differential scattering cross-section for elastic scattering in the Rayleigh regime is 
proportional to the 6th power of the particle radius with given dielectric properties, DLS 
may be expected to be sensitive to agglomeration or presence of larger particle species. 
Additionally, significant agglomeration is expected to lead to a higher intensity at second 
diffraction mode which is not observed. Also in the nanopore data, significant 
agglomeration of viruses can block the pore which leads to long lasting dwell times in 
contrast to what is observed in our experiments. So taken together, our data suggest that a 
small fraction of viruses (7%) get perforated, while a negligible fraction (< 10-3% based on 
Rayleigh scattering assumption) get agglomerated, and the remaining largest fraction of 
the viruses (93%) are fragmented. 
 






 While DLS provides an ensemble averaged estimate of the particle size distribution, it 
does not provide information at the single particle level. Our experiments suggest nanopore 
single-particle conductance measurements to be helpful in detecting intact viruses in small-
volume samples (∼0.5 µl) to characterize morphological changes caused by laser treatment 
and inactivation.  
 
Conclusion 
The ultrashort pulsed laser technology presented here can be readily used for rapid and 
effective disinfection of viruses in a label free manner. Applying this technology to 
disinfect viruses can lead to some changes in the viruses which needs to be monitored with 
high precision. Nanopore technique allowed us to detect intact viruses and monitor the 
effect of fs laser on a model virus at the single virus level. Analysis of changes in the ionic 
current through the nanopore provides information about size and physical properties of 
viruses before and after laser treatment. To the best of our knowledge, this is the first time 
that nanopores have been used to monitor changes induced by an inactivation method in 
viruses.  
Our data are a promising step towards developing a label-free detection technique that 
can also be used as an effective method for monitoring the survival fraction of viruses using 
low sample volume, high precision and fast assay time.  
 
Materials and Methods 
Femtosecond laser irradiation. Femtosecond laser pulses from a Legend Elite Duo 
(Coherent Inc.) A Ti-sapphire regenerative amplifier system was used as the excitation 
source in this study. This laser produces a continuous train of 35 fs pulses at a repetition 
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rate of 1 kHz. The output of the second harmonic generated by a ~ 1mm thick BBO crystal 
with a wavelength centered at ∼400 nm was used to irradiate the virus samples, with a 
combined pulse energy of the second harmonic and fundamental of about 2.5 mJ. Figure 
4-1a depicts the experimental setup. The laser beam with spot size ∼1 cm2 was incident 
upon a typically 1 cm quartz cuvette containing 2 ml of virus sample while a stirrer was 
used to homogenize the virus’s interaction with the laser beam. For φX174 sample with 
1012 pfu ml–1 concentration, the laser treatment is made by exposing 250 µl of viruses in 2 
mm cuvette. The typical sample exposure time was 15 minutes. All experiments were 
carried out at 22 °C, and all samples were immediately stored at 4 °C after irradiation. 
Experiments were carried out in triplicate. 
 
Virus sample preparation. φX174 samples with 2 × 1012 plaque forming unit (pfu) per 
ml concentration (Promega TiterMax φX174 Bacteriophage) in 0.05 M sodium tetraborate 
were stored at −80 °C. Before the experiment, samples were thawed to room temperature, 
aliquoted, and kept at 4 °C. For diluted samples, φX174 spiked feed solutions were 
prepared by serial dilution in Sorenson’s buffer to the final concentration of approximately 
106 pfu ml–1. 
 
Infectious plaque assay. To count the φX174 in the solution, samples were diluted with 
Sorensen’s buffer dilution blanks, to bring plaque to within a statistically valid range of 
30–300 plaques per plate. Samples were assayed in triplicate by adding 0.1 ml of diluted 
sample and 0.1 ml of host cell suspension to a test tube containing 3 ml of molten (46 °C–
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48 °C) φX174 overlay agar consist of 10 g of tryptone peptone (Difco), 8.5 g of agar (Difco) 
and 5 g of NaCl per liter of reagent water. Then the solution containing host cell and 
bacteriophage was vortexed and transferred to the φX174 bottom plate agar (2.5 g of NaCl, 
2.5 g of KCl, 10 g of tryptone peptone from Difco, 10 g of agar from Difco, and 1 ml of 1 
M CaCl2 per liter of reagent grade water) and incubated overnight at 37 °C. Then plaques 
were counted and the corresponding bacteriophage concentrations were reported as pfu 
mL–1. Sorensen’s phosphate buffer (pH 7.3), φX174 bottom plate agar, and φX174 overlay 
agar were purchased from Northeast Laboratory Services (Winslow, ME). 
 
Nanopore device fabrication and measurement. Our electrical detection system is 
composed of a nanopore formed in a 50 nm-thick insulating silicon nitride (SiN) 
membrane. The SiN is deposited on a silicon substrate with 2 micron silicon dioxide 
previously grown on, which is chemically etched by potassium hydroxide (KOH) to obtain 
a freestanding membrane. The electron beam of a JEOL 2010F transmission electron 
microscope (TEM) was finely focused on the membrane in order to make a pore with 
controlled size [24]. The choice of 38 nm nominal diameter of the nanopore was based on 
the known radius of the virus derived from its x-ray structure. Several slightly smaller and 
larger nanopores were tested to obtain the optimal pore size. A more detailed systematic 
study was not attempted. The as-fabricated nanopore chip is then mounted in a 
fluoropolymer cell that allows electrical measurement of ionic current through the 
nanopore. The cell is filled with 0.1 M KCl solution (16.1 mS cm−1 conductivity), buffered 
to pH 7 using 10 mM tris. The silver–silver chloride (Ag/AgCl) electrodes are inserted in 
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both cis- and trans-chambers, and a DC voltage is applied to flow current and drive charged 
molecules through the pore. 
 
Data acquisition and analysis. A Chimera VC100 (Chimera Instruments LLC) was used 
for recording the ion current through the nanopore. Data was digitized at 4.17 MS s−1, and 
saved to the computer at a 1 MHz bandwidth. Prior to analysis, recordings were further 
filtered using a 100 kHz digital low-pass filter. To verify the pore’s stability, before the 
introduction of a virus sample to the nanopore, several seconds of current were collected 
to ensure that no event is detected and the baseline current is stable. Three key independent 
parameters are extracted from the nanopore data: the dwell time of viruses at the pore, td, 
the fractional current blockade, FI, and the inter-event waiting time, δt, from which virus 
capture rates can be extracted. 
 
Dynamic light scattering (DLS). In order to obtain information on the size distribution of 
viruses in an ensemble manner, we performed DLS measurements using the Zetasizer Nano 
S90 from Malvern Corp. This DLS measurement is based on the Brownian motion of 
spherical particles; using the Stokes–Einstein relation to determine the particle size based 
on measured diffusion constant of particles 195 For the size measurement, φX174 virus with 
1012 pfu ml–1 concentration and φX174 virion DNA (New England Biolabs) with 1000 µg 
ml–1 concentration, are diluted by 8-fold and 30-fold respectively in 10 mM Tris. An 
aliquot of about 80 µl of the diluted samples is transferred to the cuvette for DLS analysis 




CHAPTER FIVE: Suggested future work 
 
We are the pioneers of the plasmonic enhancement of pathogen inactivation. Although this 
thesis develops the technology for a specific application, safe production of monoclonal 
antibodies (mAb), a fundamental understanding of the mechanism(s) underlying plasmon 
enhanced photonic microbe inactivation has also relevance for patient-related applications, 
for instance, to fight antibiotic-resistant topical infections, and to sterilize dermal and other 
acute wounds, etc. Suggested future work will mainly focus in the following aspects: 
• Exploring full spectrum of materials for nanoparticles such as TiN 
• Exploring inactivation of challenging pathogens such as Ebola, HIV and antibiotic 
resistant bacteria 
• Sterilization of human blood product 















APPENDIX I: TEM image of MLV particles after femtosecond laser exposure   
 
Figure AI-1 : TEM image of MLV particles after exposure to 35 fs laser pulses for 10 s. Laser 
power was 3 W.  Images were acquired at different magnifications after staining with OsO4. Virus 




APPENDIX II: No efficient inactivation without laser exposure 
One potential concern for the observed pathogen inactivation in the presence of gold NRs 
is the potential toxicities of these materials. In all experiments that involved NRs, we 
included two control samples: one that consists of a pathogen sample with no NRs and no 
laser exposure which was held under refrigeration during the experiment, and a second 
pathogen sample with the same NR concentration as the laser-treated sample, which was 
held at room temperature but without laser exposure. These control samples were included 
to check for loss of pathogen titer in the presence of NRs with no laser exposure. The overall 
low reduction values in pathogen inactivation in the absence of laser exposure (Figure AII-
1) compared to the laser-treated samples (Figure 3-3C and Figure 3-5), rule out NR toxicity 
as cause for the observed pathogen inactivation and, instead, support a plasmonically 
enhanced photonic pathogen inactivation effect. 
 
Figure AII-1 |LRV| obtained for φX174 (V) in flow-through mode with different flow rate (2mL/hr 
and 100 mL/hr), and A. laidlawii, B. subtilis, E. coli in batch mode after incubation with a nanorod 




APPENDIX III: Ionic Conductance and Physical Diameter of Viruses 
 
Nanopore conductance  
This material is intended to provide details on methodology adopted to understand the 
connection between ionic conductance and physical diameter of viruses. The resistance of 
an open pore, Ro is the sum of the series 
combination of the pore's geometric 
resistance, Rp and its access resistance, Ra, 
which is a consequence of ions converging to 
a small aperture from a semi-infinite 
reservoir.196 One simple model is to consider 
the nanopore as a cylinder with effective 
height of heff. As shown in Figure. AIII-1a 






This quantity can provide a simple method for estimating the pore height based on the open 
current which in our case is 35 nm.  
1
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Figure AIII-1 a) Open pore conductance of 
low-aspect-ratio pores consists of cross-pore 
resistance, Rp, and the access resistance, Ra, 
connected in series. b) virus translocation 
increases the transmembrane resistance. 
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When a spherical virus with diameter d, is translocating through the pore (Figure AIII-1b) 
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Log - Lin plots for the upper bound survival fraction  
Figure AIII-2 shows the data better at small values. At , the data reached 
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